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ABSTRACT
AGGREGATIBACTER ACTINOMYCETEMCOMITANS EXPLOITS AND
MODULATES THE IMMUNE RESPONSE BY HUMAN NEUTROPHILS FOR
SURVIVAL IN THE ANAEROBIC ENVIRONMENT
Hazel Ozuna
April 20, 2022
Aggregatibacter actinomycetemcomitans (Aa) is a Gram-negative facultative
anaerobe and an opportunistic oral pathogen, strongly associated with localized
periodontitis and other inflammatory diseases. Periodontitis is a chronic inflammation of
the periodontium resulting from the inflammatory response of the host towards the
dysbiotic microbial community present at the gingival crevice. The host immune response
creates a hostile environment for microorganisms; therefore, it is important for Aa to be
able to regulate the necessary genes to survive and thrive in such an environment. Aa
expresses several virulence factors such as a cytolethal distending toxin (Cdt),
lipopolysaccharide (LPS) and leukotoxin A (LtxA), that allows it to evade the immune
response. For example, LtxA, considered a major virulence factor, targets leukocytes by
creating pores on their membranes leading to cell lysis. LtxA has also been shown to
provide Aa resistance against internalization and killing by neutrophils, however the effect
of the toxin on neutrophils at a non-lethal level is often overlooked. At the subgingival
pocket Aa is in a tug-of-war scenario where immune cells will secrete molecules such as
vi

catecholamines (i.e., epinephrine) to sequester residual metals, so these are not available
as nutrients. To compete for such mineral bacteria have evolved different mechanisms,
such as two-component systems (TCS) that allow them to assess their environment and
adjust accordingly. Aa expresses the QseBC TCS composed of the sensor protein QseC
and the response regulator QseB. Previously, catecholamines and iron were identified as
the signals that activate the QseBC TCS in Aa, necessary for the organism to acquire iron
as a nutrient to survive in the anaerobic environment. However, the source of
catecholamines had not been identified at the time. The main objectives presented in this
dissertation are a) the characterization of epinephrine interaction with different components
of QseBC TCS, b) to characterize the synthesis, storage, and release of catecholamines by
neutrophils stimulated with Aa, and c) determination of the effect sublytic levels of LtxA
has on neutrophils.
Previously, our group showed that QseC, primarily the periplasmic domain of
QseC, is required for biofilm formation and virulence. A third gene was found to be coexpressed in the qseBC operon, YgiW, a protein of unknown function, but essential for
biofilm growth and virulence. Additionally, it was previously shown that in the presence
of Cat-Fe the expression of the enterobactin operon remained unchanged. Among the genes
in this operon there is the fepA gene encoding for the enterobactin receptor FepA. In this
work we investigated the interaction of different components of the QseBC TCS and
epinephrine. Using Aa mutants for the different QseBC component we determined that
FepA, QseC and the QseC periplasmic domain are necessary for Aa to interact with
epinephrine (Chapter 3). In contrast, YgiW was not required for epinephrine to interact
with Aa. Due to the high infiltration of neutrophils that is characteristic of periodontitis we
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proposed neutrophils as the epinephrine source for Aa. We present evidence of the ability
of human neutrophils to release epinephrine upon Aa challenge (Chapter 4). In addition,
we demonstrated that epinephrine is stored in azurophilic granules and proposed that Aa
gains access to it by inducing degranulation. To connect our findings, we demonstrated
that chemically define media (CDM) supplemented with iron and epinephrine from human
neutrophils promoted Aa growth and the induction of the qseBC operon.
LtxA, a major virulence factor expressed by Aa, targets neutrophils and induces
cell lysis. However, lysis only occurs when cells are exposed to high levels of the toxin,
the sublytic effects of the toxin on neutrophils remains understudied. We show that the
minimally leukotoxic Aa strain 652 caused minimal cytotoxicity in human neutrophils,
even at MOI 50 (Chapter 5). Assessment of membrane permeability confirmed that human
neutrophils suffered loss of membrane integrity. However, neutrophils were functionally
active and were able to internalize Aa at MOI 10. In contrast, Aa internalization did not
occur at MOI 50 for both the minimally leukotoxic strain or a LtxA mutant (JP2 DltxA). Aa
challenge induced the formation of cytotoxic vacuoles, which have previously been
associated with pore-forming toxins, but we observed cytoplasmic vacuolation regardless
of LtxA expression of Aa strains. Siglec-9, a sialic acid-binding immunoglobulin-type
lectin, has been associated with cytoplasmic vacuolation. Therefore, we measured Siglec9 as an alternative inducer of cytoplasmic vacuolation. We were able to show that Aa 652
enhances Siglec-9 expression in human neutrophils and that IL-8 priming before Aa
challenge further increases expression.

viii

The findings presented in this dissertation contribute to the current knowledge of
nutrient acquisition mechanisms and provides the foundation for future studies of how Aa
can modulates the inflammatory response of neutrophils through Siglec-9 activation.
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CHAPTER 1
INTRODUCTION

Periodontal Disease: cause and effect
Periodontal disease or periodontitis is defined as an inflammation of the gingiva
caused by accumulation of oral microorganisms. Most recent statistics by the Centers for
Disease Control and Prevention (CDC) report that 47.2% of adults 30 years and older are
diagnosed with some type of periodontitis (1). Poor oral hygiene is the most obvious cause
for periodontitis, but the risk of periodontitis also increases with age, gender,
socioeconomic status and education (2). The National Health and Nutrition Examination
Survey (NHANES) 2009-2012 report period found that Hispanics had the highest
prevalence in periodontitis (63.5%), followed by non-Hispanic Blacks (59.1%) and NonHispanic Whites (40.8%). The incidence of periodontitis was higher in those with less than
a high school diploma (67%) and those living under the federal poverty level (62.2%).
Other risk factors such as smoking, diabetes, medications that cause dry mouth, stress, and
genetics (1) can affect the oral cavity homeostasis and have a direct or indirect impact on
the microbiome. This in turn can promote bacterial population shifts, favoring pathogenic
bacteria.
Once host homeostasis is disrupted, bacterial communities accumulate in the subgingival pocket and form biofilms that lead to oral diseases such as periodontitis (3). The
depth of the gingival pocket increases due to continuous periodontal ligament and alveolar
1

bone destruction (4). The infection starts with the formation of plaque, which accumulates
and becomes tartar, serving as a reservoir for bacteria (4). Periodontal disease starts with
gingivitis, characterized by gum inflammation or irritation, and it can be easily reversed by
improved oral hygiene. If untreated, this is followed by bone resorption and deepening of
the sub gingival pocket, distinctive of early periodontitis, allowing bacteria to accumulate
creating a biofilm (4). Progression of periodontitis is based on further deepening of the sub
gingival pocket leading to additional bone loss. Although, prevention by means of good
oral hygiene is the best choice of treatment, dental cleanings are encouraged and for those
with more serious dental needs a more extensive treatment is recommended. Such
treatment consists of deep cleaning of the tooth roots and below the gum (scaling and root
planing), or removal of the affected teeth, and medication (5). Other types of therapies
include topical use of antibiotics or anti-inflammatories, host modulation therapy and
probiotic therapy, yet the benefits have been limited due to the multispecies organization
of oral communities (5, 6)
Periodontitis is a chronic inflammation of the periodontium caused by the
inflammatory response of the host to plaque biofilm. Recurring inflammation of the
periodontium has been associated with the initiation, exacerbation, and pathogenesis of
several other inflammatory diseases (Figure 1.1). Epidemiological data and experimental
evidence show that periodontitis plays a role in the development and progression of
atherosclerosis cardiovascular disease (7-9). Oral bacteria associated with periodontitis,
such

as

Porphyromonas

gingivalis,

Streptococcus

sanguis,

Aggregatibacter

actinomycetemcomitans (Aa) and Tannerella forsythia, have been isolated from
atheromatous plaque (10-12). In addition, a two-way relationship exists between
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periodontitis and rheumatoid arthritis (RA), where RA can be a result of periodontitis or
RA exacerbates periodontitis (13). Furthermore, P. gingivalis has been isolated from joints
of RA patients and is believed to promote RA through molecular mimicry (14). P.
gingivalis and gingipains have also been identified in the brain of Alzheimer’s Disease
patients (15-19). Recently, Dominy et al (17) used gingipain inhibitors in mouse brains to
successfully block neurodegeneration induced by gingipains. This in turn reduced P.
gingivalis bacterial load and significantly decreased the immune response against P.
gingivalis brain infection. Finally, increased levels of pathogenic oral bacteria, in particular
Fusobacterium nucleatum, have been associated with a risk of developing pre-cancerous
gastric lesions and ultimately colorectal cancer (20-22).
The tipping point: Microbial dysbiosis and the host immune response during periodontitis
Periodontal disease is a multifactorial disease, that in addition to the external risks
discussed previously, requires the invasion of bacteria into the gingiva epithelium and
bacterial persistence to drive chronic inflammation. In contrast to other diseases,
periodontitis is not caused by one bacterium but by a heterotypic microbial community
working together to destabilize homeostasis. Under normal conditions, commensal bacteria
are organized into compatible communities, and any detour from homeostasis is efficiently
cleared by the host inflammatory response, returning to the “surveillance inflammatory
state”. Any disturbance to this balance such as changes in diet, smoking habits, genetic
factors, or stress promotes changes of pH, redox potential, and nutrient availability in the
oral microenvironment, leading to a dysbiotic environment (23). Microbial shifts or
dysbiosis of the bacterial population can result in a shift from beneficial symbionts
(commensal bacteria) to predominantly pathogenic bacteria. During dysbiosis there is
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increased inflammation, the local environment becomes anaerobic and is enriched with byproducts of the immune response, such as plasma proteins and hemoglobin from bleeding.
These conditions select for anaerobic Gram-negative, proteolytic bacteria that use essential
amino acids, and hemin as an energy source and provide an environment that favors growth
and persistence of specific subsets or consortia of oral pathogenic bacteria (24, 25).
Although it has been thought of as being a shift from primarily Gram-positive bacteria to
mostly Gram-negative bacteria, dysbiosis or bacteria alone is not sufficient to cause
periodontitis (26). This is exemplified by a mouse model study (26) that demonstrated that
few oral commensals invaded the gingiva in the absence of oral pathogens, with minimal
recruitment of immune cells. In this scenario commensals were quickly cleared, and
homeostasis restored. However, the presence of periodontal pathogens with superior
invasive ability promoted a high infiltration of immune cells. The oral pathogens persisted
by resisting clearance, leading to chronic inflammation. These observations go in hand with
the current accepted model for the etiology and pathogenesis of periodontitis: the
Polymicrobial Synergy & Dysbiosis (PSD) Model (23). The PSD model postulates that
disease is not caused by an individual pathogen but by a synergistic polymicrobial
community with specific elements, a combination of functional genes, and where each
member fulfills roles that help give shape and stabilize the dysbiotic microbiota (5, 23, 2729).
The development of the diverse dysbiotic community stimulates inflammatory
responses that recruits a large infiltration of neutrophils, macrophages, and lymphocytes.
This leads to deterioration of the soft tissue around the teeth, destruction of the periodontal
ligaments and gingival fibers, and loss of attachment to the teeth. The tissue damage caused
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by the aggravated immune response provides by-products that serve as a source of nutrients
supporting the dysbiotic community. As part of the host immune response, gingival
epithelial cells release IL-8 which guides neutrophils from the circulation through the
junctional epithelial to the site of infection. Neutrophils form a protective wall between the
plaque and gingival epithelium, release antimicrobial peptides (α-defensins and LL-37) and
actively phagocytose adjacent bacteria (30, 31). Gingival epithelial cells also release
antimicrobial peptides, i.e., β-defensins and LL-37 (32). However, periodontal bacteria
have evolved mechanisms to evade or modulate the host immune response. For example,
Aa lipopolysaccharide (LPS) induces the expression of IL-1β and RANKL, activating
osteoclasts and promoting bone resorption (33, 34).
Neutrophils in the spotlight: effector functions and role in periodontitis
Neutrophils comprise of 40-60% of peripheral blood leukocytes in humans and are
a major player of the innate immune response (35). The importance of neutrophils is
exemplified by predisposition to life-threatening bacterial and fungal infections, loss
function to regulate inflammation and leukocyte adhesion deficiency in individuals with
neutropenia or genetic defects of neutrophil anti-microbial capabilities (36-38).
Neutrophils have granules packed with enzymes and other antimicrobials such as
lactoferrin and transferrin (39). There are three granules: specific, gelatinase and
azurophilic and secretory vesicles. Granules are released in a controlled and hierarchical
manner determined by the intensity of the stimulus received (40-42). Secretory vesicles are
the first granule to be mobilized, followed by gelatinase granules (40, 41). Stronger
stimulation is required to mobilize specific and azurophilic granules, for example,
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experimentally such a stimulus would be pre-treatment with latrunculin A to disrupt the
cytoskeleton and then stimulate with fMLF.
Under homeostatic conditions, mature neutrophils exit the bone marrow and enter
the circulation (43). Low concentrations of IL-8 stimulate the expression of neutrophilspecific adhesion molecules on the blood vessel wall (44-46). This interaction, in addition
to IL-8 gradient (among other chemoattractants), promotes the mobilization of secretory
vesicles. Once neutrophils cross through the endothelium, they continue to receive signals
such as an increasing IL-8 gradient released by gingiva epithelial cells, formyl peptides
(i.e. fMLF) produced by invading bacteria, the anaphylatoxin C5a (47), resulting in
mobilization of gelatinase granules. These different signals “prime” the neutrophils, by
initial activation that has them in “alert mode” that upon a second stimulus, will enhance
the response of the neutrophil. The primed neutrophil arrives and forms a defensive wall
against the tooth-associated-biofilm to prevent bacteria from reaching deeper into tissue
(48). In the infected subgingival pocket, neutrophils are exposed to an overwhelming
number of inflammatory signals that induce the release of specific and azurophilic
granules. Granules also play a key role in neutrophil phagosome maturation. Upon
internalization of a particulate stimuli, like a bacterium, recruitment of specific and
azurophilic granules to the phagosome is a key event to acquire phagosome maturation
generating a very toxic environment due to the release of antimicrobial peptides, enzymes
such as myeloperoxidase (MPO) and generation of reactive oxygen species (ROS) (49-51).
Finally, some neutrophils undergo apoptosis and are cleared by macrophages or might form
neutrophil extracellular traps (NETs). NETS arise from the release of decondensed
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chromatin histones and granule contents into the extracellular space as a last resort to
capture and or kill microorganisms (52).
This oral mucosa environment promotes a primed and hyperactivated phenotype in
neutrophils which could be potentiated by the ability of oral pathogens to modulate their
effector functions. As a result, neutrophils have been suggested to promote disease
progression, which may explain why neutrophil counts in periodontitis is correlated with
disease severity (48, 53-56).
Siglecs and their role in periodontal disease
Neutrophils can experience cytoplasmic vacuolation when under stress and is often
accompanied by cell death (57-59), but the functional role of vacuolization remains
unclear. Cytoplasmic vacuolation occurs when a cell is exposed to a certain inducer and its
effects can be transient or irreversible depending on the concentration and time of exposure
(60-62). Bacterial, viral pathogens or natural and artificial low molecular weight
compounds serve as inducers of vacuolization. Further, cell death associated with
cytoplasmic vacuolization in neutrophils has been found to be mediated by sialic acidbinding Ig-type lectin (Siglecs) in a caspase-independent manner (63) and is dependent on
the proinflammatory cytokine environment (64). In addition, delayed neutrophil apoptosis
is associated with acute and chronic inflammatory diseases (i.e. periodontitis) and is
influenced by the overexpression of neutrophil survival cytokines such as G-CSF (64, 65).
Siglecs are type I transmembrane proteins present in the membrane of most white
blood cells and have an N-terminal Ig domain that recognizes sialic acid-containing
glycans. These are a built-in surveillance system that aids in distinguishing from self and
non-self, and helps regulate unwanted immune responses (66-70). These proteins have
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conserved cytoplasmic tyrosine-based motifs, that consist of a membrane-proximal
immunoreceptor tyrosine based inhibitory motif (ITIM) and a membrane-distal ITIM-like
motif (71). Inhibition of immune responses normally occurs via the recruitment of tyrosine
phosphatases, such as SHP1 and SHP2, by their cytoplasmic ITIM domain (72, 73). Siglecs
identified in both humans and mice and what cells express them are shown in Figure1.2.
Human neutrophils express only Siglecs-5/14, which are expressed as polymorphic
paired receptors, and Siglec-9 (64). Siglecs-5/14 paired expression is believed to be an
evolutionary response to counteract pathogens that cloak themselves in sialic acidcontaining glycans in order to suppress immune response (70). Different members of the
Pasteurellaceae group, such as Haemophilus influenzae, Aa and Pasteurella haemolytica
have been found to possess sialic acid on their LPS structures (74, 75) and may use this as
a disguise to modulate and evade the host immune response. For example, H. influenzae is
known to engage Siglec-5 to suppress cytokine production by myeloid cells (76). However,
because Siglec-5 and Siglec-14 transduce opposing signals, when sialylated-adornedbacteria binds Siglec-5 (inhibitory) it will also bind Siglec-14 (activating) and initiate the
p38 mitogen-activated protein kinase (MAPK) and AKT signaling pathways (77). The
importance of this paired expression is exemplified in individuals with a SIGLEC14-null
polymorphism, where only Siglec-5 is expressed. In these individuals, bacteria escape
surveillance and successfully suppress phagocytic killing by neutrophils (78). Further,
different genome wide analysis studies (GWAS) done with samples groups from Chinese
Han, German, Netherland, Turkey, northwestern Europe and British origins coincided in
reporting that SIGLEC5 and DEFA1A3 loci were associated with both aggressive and
chronic periodontitis (79-82).
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It has been shown previously that Siglec-E (Siglec-9 mouse homolog) is involved
in modulating neutrophil functions, including induction of apoptosis, inhibition of cellular
activation, suppression of migration, modulation of oxidative stress, and regulation of
inflammatory cytokines secretion (83). Recent work demonstrated that Gram-negative
bacteria enhance Siglec-E activation in murine neutrophils and in turn dampens the innate
response toward Gram-negative bacteria (84). Siglec-9 has also been shown to negatively
regulate the innate immune response against sialylated bacteria (71). A role for Siglec-9 in
periodontitis has been highlighted in a recent review by Sudhakara et al. (85) where sialic
acid adorned P. gingivalis interacts with Siglec-9 and attenuates neutrophil inflammatory
signaling. However, further studies will be required to confirm this activity. Siglec-9 has
been also associated with vacuolization or the formation of cytoplasmic vacuoles (63).
Ligation of Siglec-9 in a pro-inflammatory environment diverts to a caspase-independent
cell death, ROS production and vacuole formation (86). Further, neutrophils from RA
patients, a disease associated with periodontitis and Aa, demonstrated increased Siglec-9
expression (64). Additionally, both Siglec-5 and Siglec-9 have been shown to suppress
NETosis by modulating neutrophils activation and ROS generation (87).
A. actinomycetemcomitans contribution to periodontal disease and host immune response
modulation
Aggressive periodontitis is one of the three sub-classifications of periodontal disease
and is characterized by rapid loss and destruction of the bone (4, 88, 89). In some cases, it
has been associated with abnormalities with phagocyte function and strongly associated
with infection of Aa (88, 90, 91). Aa is a Gram-negative opportunistic oral pathogen,
facultative anaerobe, and non-motile coccobacillus of the Pasteurellaceae family (92).
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Other members of the Pasteurellaceae family include Haemophilus influenzae and
Actinobacillus pleuropneumoniae. In addition to being associated with aggressive
periodontitis, Aa has been associated with other diseases, like cardiovascular diseases,
atherosclerosis, urinary tract infections, brain abscesses, among others (93-96).
The main Aa strain used in this work was the afimbriated, smooth-colonymorphotype strain 652, serotype c which has been previously referred as a minimally
leukotoxic strain of Aa (97). There are five serotypes (a-e), with variation in the global
population in serotype burden, with a, b, and c being globally dominant, while d and e are
rare in humans (98, 99). However, Fine et al. (100) showed that Aa 652 cultured under
anaerobic conditions has increased cytotoxicity due to increased leukotoxin A production.
The Aa 652 serotype c has been isolated from both healthy and periodontitis positive
patients and is considered an opportunistic pathogen (100, 101). Finally, there is strong
racial tropism in the distribution of Aa strains among periodontitis positive individuals
(100, 102-104) where ancestry and socioeconomic status plays a major role. The low
leukotoxic strains of Aa are found mostly in individuals of Caucasian ancestry compared
to the more leukotoxic strains found in those of African ancestry (100, 102, 105-107).
In periodontitis Aa contributes to tissue inflammation, destruction, and bone
resorption by expressing several virulence factors (Table 1.1). As discussed above, Aa
expresses and secretes a 116 kDa leukotoxin A (LtxA) of the repeats-in-toxin (RTX) family
of pore-forming bacterial toxins that target neutrophils (Figure 1.3), monocytes and
lymphocytes (108, 109). In neutrophils, LtxA induces the release of granules (110) or when
in large concentrations, cell death (111). JP2 is a highly leukotoxic strain of Aa, considered
a pathogenic strain that expresses 8 to 10-fold more LtxA than the 652 strain. JP2 ltx operon
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is transcribed from two promoters in comparison to 652 which has a 530bp region present
in its promoter which contains a potential attenuator, resulting in reduced transcription of
the ltx operon (112, 113). Individuals infected with the highly leukotoxic strain JP2 have
early onset periodontitis (97, 114).
The cytolethal distending toxin (Cdt) is a genotoxin and it has three subunits: CtdA,
CdtB and CdtC. CdtA and CdtC subunits are required to bind the holotoxin to the plasma
membrane of the target cell and gain entry as a dimer. CdtB as its active unit translocates
to the nucleus and using its DNase activity induces DNA lesions that lead to cell cycle
arrest at the G2/M interphase. (115). CdtB can also induce cell-cycle arrest and apoptosis
through its phosphatase activity (116). CdtB induces apoptosis in T cells, monocytes, and
gingival epithelial cells and promotes the release of IL-1β, IL-6, IL-8 by peripheral blood
mononuclear cells (PBMCs), monocytes and macrophages (117-119). At high
concentrations, CdtB promotes a decrease of IL-12 and IL-10 and increases IL-1β and
TNFα, thus impairing phagocytosis and nitric oxide (NO) production by macrophages
(120).
Outer membrane vesicles (OMVs) play a very important role in Aa ability to evade
complement. These vesicles serve as a decoy that triggers complement activation through
LPS and take in complement components (121). In turn, LPS of some Aa strains (i.e. A.
actinomycetemcomitans Y4) can bind strongly to C3b, blocking the interaction between
complement-derived opsonins with LPS, decreasing the neutrophil complement-dependent
response (122). OMVs also contain outer membrane proteins (Omp) (123) such as Omp29
that bind C4-binding protein, inhibiting the activation of the classical and mannose-binding
lectin (124) complement pathways (125). Further, Omp29 (Figure 1.3) is associated with
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entry into gingival epithelial cells by upregulating F-actin rearrangement. A third Omp,
Omp100 (ApiA), is produced by Aa in response to the presence of H2O2 (126). Omp100
captures the alternative complement pathway negative regulator, Factor H, and deposits it
at the cell surface to modify C3b into an inactive form (127). Additionally, Omp100 aids
in Aa adhesion and invasion of keratinocytes (127, 128). The VT745 strain of b serotype
of Aa resists phagocytosis killing by blocking complement access to LPS through serotypeb-specific polysaccharide antigen (129).
In early stages of periodontal disease, Aa makes use of lactic acid produced by
Streptococcus sp. as a nutrient to increase its population (Figure 1.3). Production of H2O2
by Streptococcus sp. and iron limitation serves as an environmental cue for Aa to activate
the fur transcriptional regulator which induces the expression of dispersin B (dspB) to
facilitate the release of Aa from the biofilm and migrate deeper into the gingival pocket
(130). This environmental cue also activates the oxygen resistance transcription regulator
(oxyR), which regulates the expression of Omp100 and catalase (KatA) (126). Catalase aids
in the degradation of hydrogen peroxide produced by neutrophils and streptococci (131),
protecting Aa from oxidative damage. This in turn increases oxygen availability allowing
Aa to shift from fermentative metabolism to respiratory metabolism.
Iron transport systems
Iron limiting conditions occurs during an active infection, where host molecules
such as lactoferrin or transferrin (produced by leukocytes) sequester free iron, so it is not
available to bacteria. To counter this, bacteria express high affinity iron scavenging
molecules, known as siderophores (132). Enterobacteria (e.g., Echerichia coli) encode a
siderophore known as enterobactin to sequester iron in the host environment (133-136).
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Salmonella typhimurium and E. coli express a siderophore receptor, the enterobactin
receptor, along with an ATP-binding cassette (ABC) transporter (134, 135) necessary for
iron uptake. On the other hand, Bordetella uses catecholamines already in the environment
(from the host) to scavenge for iron and catecholamines are recognized by a siderophore
receptor on its membrane (137-140). Interestingly, Aa is not able to produce siderophores
(141), but it does express an enterobactin receptor and an ABC transporter (91). This
enterobactin operon in Aa consists of four open reading frames (ORFs) encoding the ABC
transporter, permease, periplasmic – binding proteins and FepA (enterobactin/siderophore
receptor) (142).
Alternatively, iron uptake may be carried out by the ferrous iron transport system
(Feo) and periplasmic-binding protein-dependent transport (PBT) (143-146). This system
may represent the predominant iron transport system at low oxygen conditions when
ferrous iron is stable and is more prevalent than ferric iron (147). In contrast, when ferric
iron is predominant, it is chelated by ferric iron reductases and subsequent uptake is
mediated by ferrous permeases (132, 148, 149) .
QseBC two-component system and its importance for iron transport in A.
actinomycetemcomitans
In order to persist and colonize in a given niche is crucial for bacteria to adapt
quickly to environmental changes. Bacteria has evolved mechanisms such as twocomponent systems (TCS) that allows them to sense external changes and regulate gene
expression accordingly. TCS (Figure 1.4) are phosphorelay systems that in most cases,
sense an outer cell signal and subsequently regulate the expression of targeted genes inside
the cell (150-152). TCS may respond to several stimuli such as pH, temperature, and ion
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concentration (i.e., zinc and iron). The prototypic TCS consists of two components, as the
name entails, a sensor, and a response regulator protein. The sensor protein is a histidine
kinase (HK) homodimer comprising a sensor domain and a cytoplasmic kinase domain.
Interaction of the sensor domain with its cognate signal induces a conformational change
that activates the kinase domain. The kinase domain phosphorylates the response regulator
which in turn functions as a DNA binding protein or transcription factor, promoting gene
regulation.
The QseBC TCS is associated with quorum sensing and is highly conserved in
Enterobacteriaceae and Pasteurellaceae (89) but the signal recognized by members of
these bacterial families differs among species. The QseC (sensor) homolog in H.
influenzae, FirS, is activated by ferrous (Fe2+) iron and zinc (153), whereas catecholamines
and autoinducer-3 (AI-3) can activate QseC in E. coli (89, 154). The QseC signaling
cascade in Enterobacteriaceae is more complex than that of Pasteurellaceae. In E.coli
QseC serves as a global virulence regulator as it not only phosphorylates its cognate
response regulator QseB, but also the non-cognate response regulators QseF and KdpE
(155). Each of these response regulators control the expression of the virulence factors,
shiga toxin and LEE-encoded regulator (Ler), respectively, integrating the QseBC
signaling cascade to the QseEF and KdpDE TCS. (88), demonstrated that mutation of the
qseC gene resulted in a decrease in biofilm biomass and mice inoculated with the qseC Aa
mutant showed no bone resorption compared to wild type, highlighting the requirement of
QseC for Aa biofilm growth and virulence.
In Salmonella enterica, the ygiW (renamed virulence and stress-related periplasmic
protein (visP)) gene was identified upstream of the qseBC operon (156). VisP (a precursor
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to YgiW in E. coli) binds to the sugar moiety of the peptidoglycan, inhibiting the Fe2+/αketogluterate-dependent dioxygenase (LpxO) resulting in decreased LPS modification and
increased resistance to stressors when bacteria were internalized and replicating within the
macrophage vacuoles (156). On the other hand, in the same study using a murine colitis
model VisP functioned independently of LpxO and provided resistance against cationic
antimicrobials peptides. In E.coli, YgiW was shown to play a role in stress response by
providing resistance against hydrogen peroxide, cadmium and acid stress (157). The
transcription of ygiW has been shown to be regulated by QseB in S. enterica (158), H.
influenzae (153) and Aa (92). In E.coli, YgiW was shown to play a role in stress response
by providing resistance against hydrogen peroxide, cadmium and acid stress (157).
In Aa, the qseBC operon encodes the genes for QseC, a sensor molecule, and QseB
the response regulator (88). In Aa, QseC phosphorylates the only response regulator
identified to date, QseB, and this results in upregulation of genes associated with anaerobic
metabolism and respiration (91), whereas genes involved in iron uptake and transport are
downregulated (91). Deletion of the qseB gene in Aa demonstrated that a functional QseB
protein is necessary for the expression of the ygiW-qseBC operon, suggesting that qseBC
is auto-regulated (92). Weigel et al. (91), showed that in Aa both catecholamines
(epinephrine and norepinephrine) and iron (ferrous and ferric iron) are the signals that
activate QseC (Figure 1.5) and promote qseBC expression and bacterial growth. Novak et
al. (88), demonstrated that mutation of the qseC gene resulted in biofilm biomass decrease
and mice inoculated with a qseC Aa mutant showed no bone resorption compared to wild
type, highlighting the requirement of QseC for Aa biofilm growth and virulence. The
qseBC operon of Aa shares 70% sequence similarity with E. coli; however, the organization
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of the operon is different (89). In both bacteria, the qseBC locus is associated with the ygiW
gene, which encodes a putative periplasmic protein of the bacterial oligonucleotide/oligosaccharide-binding (OB)-fold (BOF) protein family (159, 160), but it
differs in transcription of ygiW relative to the qseBC operon, due to the attenuator stem
loop found in the intergenic region between ygiW and qseBC (92). Real time PCR of qseB,
qseC and ygiW, in Aa, showed that all three genes were transcribed in a primary transcript
(92). Promoter mapping supported this by indicating that ygiW gene is part of the qseBC
operon (92). Although, no known function has been identified for YgiW in Aa member of
the BOF protein family can act as scaffolds in ligand binding (160). Although, little
characterization of BOF proteins exist, they have been linked to stress responses (161,
162).
Interkingdom signaling: catecholamines as the common language
Catecholamines (e.g., dopamine, epinephrine (adrenaline) and norepinephrine
(noradrenaline)) are hormones made in the adrenal glands and are released upon physical
or emotional stress. These are also known as monoamine neurotransmitters, which
structure comprises a catechol and side chain amine. As a defense mechanism by the host,
catecholamines are also used as antimicrobials to sequester any free iron in the environment
so it is not available to pathogens (90) and “starve” microbes, this is known as nutritional
immunity. These molecules also serve a role in proliferation, differentiation, apoptosis, and
cytokine production in lymphocytes and PBMCs (90). Additionally, it has been shown that
catecholamines enhance neutrophil activity, modulate cytokine and adhesion molecule
expression, and can regulate phagocytosis (163-165). In mice, macrophages and
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neutrophils are known to release catecholamines when stimulated with LPS (166).
Therefore, the inflamed subgingival pocket is a catecholamine rich environment for Aa.
The newly emerging field of microbial endocrinology (167, 168) studies the
communication

or

inter-kingdom

signaling

(155)

that

has

evolved

between

microorganisms and hosts. The study of inter-kingdom signaling includes the study of
hormonal communication, where microorganisms respond to the host neurohormones as
environmental cues to regulate the expression of genes necessary for virulence and survival
(167, 169-173). It has been shown that in chemically defined medium, where
catecholamines presence and concentration are controlled, catecholamines activate
signaling pathways that promote the expression of genes required for bacterial iron uptake
and growth (154, 174, 175). Gram-negative bacteria such as Yersinia enterocolitica,
Pseudomonas aeruginosa and E. coli respond to epinephrine, norepinephrine, dopamine
and dopa in the environment by regulating genes necessary for bacterial growth (176).
Catecholamines have also been shown to be used as cues by pathogenic and probiotic
strains of Enterococcus faecalis to regulate the expression of genes involved in biofilm
formation and adhesion (177).
In

both

Bordetella

bronchiseptica,

Bordetella

pertussis

epinephrine,

norepinephrine and dopamine induced bfeA transcription, resulting in BfeA receptor
production (outer membrane receptor) and increased bacterial growth (137, 138). Further,
it was shown that norepinephrine facilitates B. bronchiseptica iron sequestration from ironloaded transferrin (137, 138, 154) Freestone et al. (154) demonstrated that norepinephrine
complexed with host iron-loaded transferrin and lactoferrin and that E. coli can bind and
use this as a source of iron. Their findings suggested that transferrin and lactoferrin affinity

17

to iron decreased when in complex with noerpinephrine, due to conformational changes
induced by the complex or by norepinephrine having a higher affinity for iron than
lactoferrin and transferrin (154). This was studied and confirmed by Sandrini et al. (178),
that structurally demonstrated that catecholamines, have the ability to interact with ironloaded transferrin or lactoferrin and remove iron, making it available for bacterial iron
uptake systems. Although, providing iron to bacteria is not the intended function for
catecholamines, microbes have found a way to exploit this and use it to their advantage.
Rationale and Significance
Previously, Cat-Fe was identified as the signals that activate QseBC, yet a source
for catecholamines in the oral cavity has not been identified. Neutrophils are found in large
numbers at periodontitis active sites, and it has been shown that murine neutrophils release
catecholamines and these in turn can sequester free ions such as iron and make them
unavailable to bacteria (154, 166, 178). However, bacteria can exploit catecholamines from
the host to obtain iron as a nutrient and regulate genes involve in virulence and growth
(137, 138, 178). In the presence of Cat-Fe Aa growth is increased as well as the regulation
of genes involved with iron storage and metabolism in the anaerobic environment.
Therefore, we hypothesize that Aa utilizes catecholamines from the host environment and
via QseBC, primes metabolism for growth in the anaerobic sub-gingival environment.
Additionally, Aa produces a pore forming toxin known as LtxA, these types of
toxins are associated with the formation of cytoplasmic vacuoles (58). Aa has also been
shown to express sialic acid on its LPS structure like other members of the Pasteurellaceae
family (85, 179) and recently, in neutrophils Gram-negative bacteria have been
demonstrated to exploit the Siglecs surveillance system by increasing Siglec-9 expression,
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dampening the neutrophil inflammatory response (72, 83, 84). Thus, we propose that Aa
induces cytoplasmic vacuolation independent of LtxA expression and enhances Siglec-9
expression to dampen the inflammatory response of neutrophils.
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Figure 1.1. Periodontitis plays a role in several diseases at distal sites
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Figure 1.2. Identified Siglecs in humans and mice and their structures (70)
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Figure 1.4. General schematic of a two-component system
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CHAPTER 2
MATERIALS AND METHODS

Human neutrophil isolation and purification
Recruitment of human donors, blood draws, and use of required materials were
done in agreement with guidelines approved by the Institutional Review Board of the
University of Louisville. Human neutrophils were isolated from whole blood of healthy
donors using plasma-Percoll gradients as previously described (199). When necessary,
neutrophils were further purified to obtain >99% pure population. Purification was carried
by negative magnetic selection using the Easy Sep Human neutrophil isolation kit
(Stemcell Technologies, Vancouver, BC, Canada). Cell purity was assessed by
simultaneously staining with FITC-conjugated anti-CD66b (clone G10F5; BioLegend, San
Diego, CA, USA) and APC-conjugated anti-CD16 (clone CB16; eBioscience, San Diego,
CA, USA) antibodies and determining the percentage of CD66b+CD16+ cells using a BD
Celesta flow cytometer (BD Biosciences, San Jose, CA, USA) and FlowJo for analysis
(FlowJo, LLC, Ashland, OR, USA). Both pure (>90–95%) and highly pure (>99%)
neutrophils were cultured in RPMI-1640 medium without phenol red (Sigma-Aldrich, St.
Louis, MO, USA) supplemented with 2 mM L-glutamine (Sigma-Aldrich, St. Louis, MO,
USA) and 5% human serum (Atlanta Biologicals, Flowery Branch, GA, USA).
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Bacteria strains and media
In this study we utilized the Aa 652 serotype c strain, a minimally leukotoxic,
afimbriated, smooth colony-morphotype variant. Considered an opportunistic pathogen,
this strain has been isolated from healthy and in large numbers in periodontitis positive
individuals (100, 101). Aa strains (Table 2.1) were propagated in brain-heart infusion (BHI,
Difco, BD Biosciences, Franklin Lakes, NJ, USA) BHI broth or BHI agar (1.5% agar)
supplemented with NaHCO3 (0.2 μM), bacitracin (50 µg/ml) and vancomycin (50 µg/ml),
unless indicated otherwise. Aa was grown at 37°C under microaerophilic conditions in a
closed tube, unless indicated otherwise. The Aa mutant strains (all in Aa 652 background,
see Table 2.1) used for experiments were previously constructed by Juarez-Rodríguez et al
(92): Aa DqseC (non-polar qseC gene deletion mutant, spectomycin 50 µg/ml), Aa qseCDpr
(QseC sensor protein with an in-frame deletion of the periplasmic sensor domain,
spectomycin 50 µg/ml), Aa DqseC-comp (non-polar qseC gene deletion mutant
complemented with a single genomic copy of the qseC gene, spectomycin 50µg/ml), Aa

DfepA (in-frame deletion in the FepA gene, spectomycin 50 µg/ml), Aa DfepA-comp (inframe deletion in the FepA gene complemented with a single genomic copy of the fepA
gene, spectomycin 50 µg/ml), and Aa DygiW (in-frame deletion in the ygiW gene,
spectomycin 50 µg/ml). Escherichia coli (E. coli) BL21 cultures (Table 2.1) containing the
plasmids pDJR1 and pDJR3 (Table 2.2) were cultured in Luria-Bertani broth (LB) or
propagated in LB agar plates (1.5% agar) supplemented with tetracycline (50 μg/mL),
kanamycin (25 μg/mL). The Aa strain containing the plasmid pDJR29 (Table 2.1), which
contains the lacZ gene controlled by the QseBC operon promoter (200), was used in bgalactosidase assays and was grown under anaerobic conditions in chemically define media
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(CDM, Table 2.3) (201), supplemented with kanamycin (25 µg/ml). The JP2 and JP2 DltxA
of serotype b, is a pathogenic wild type strain of Aa and considered a highly leukotoxic
strain (produces 8-10 times more LtxA than Aa 652). These strains were grown under the
same conditions as the Aa 652 strain. All reagents used in anerobic experiments were
oxygen-depleted.
Filifactor alocis (Fa) ATCC 38596 was cultured in BHI broth supplemented with
20 mg/mL yeast extract, L-cysteine (0.1%), and arginine (0.05%) for 7 days anaerobically
at 37◦C as previously described (Armstrong, 2018 #749;Armstrong, 2016 #159;Socransky,
1985 #630). Peptoanaerobacter stomatis (Ps) strain CM2 was cultured anaerobically at
37°C in tryptic soy broth supplemented with 20 g/liter yeast extract, 1% hemin, and 1%
reducing agent (37.5 g/liter NH4Cl, 25 g/liter MgCl2·6H2O, 5 g/liter CaCl2·2H2O, 50
g/liter l-cysteine HCl, 5 g/liter FeCl2·4H2O), as previously described (202).
A. actinomycetemcomitans challenge, epinephrine detection and neutrophil viability
Human neutrophils (3 x 106 cells/ml) were challenged in suspension with Aa at a
multiplicity of infection (203) of 50 at 37°C in a shaking water bath, unless indicated
otherwise. As a positive control for epinephrine release, neutrophils were treated with
latrunculin A (1μM, Sigma-Aldrich, St. Louis, MO, USA) for 30 mins, followed by
stimulation with N-formylmethionyl-leucyl-phenylalanine (fMLF, 300nM, SigmaAldrich, St. Louis, MO, USA) for 5 mins at 37°C in a shaking water bath. At the end of
incubation samples were centrifuged at 6,000 xg for 30 secs, supernatants were collected
and supplemented with 100X Halt Protease and Phosphatase inhibitor single-use cocktail
(Thermo Fisher Scientific, Waltham, MA, USA). The pelleted cells were lysed with icecold 1X lysis buffer (10 µl per 1 x 106 of cells; [20 mM Tris-HCl [pH 7.5], 150 mM NaCl,
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1% [vol/vol] Triton X-100, 0.5% [vol/vol] Nonidet P-40, 20 mM NaF, 20 mM NaVO3, 1
mM EDTA, 1 mM EGTA, 5 mM phenylmethylsulfonyl fluoride [PMSF], 2 mM
diisopropylfluorophosphate [DFP], 21 μg/ml aprotinin, and 5 μg/ml leupeptin]). Lysates
were centrifuged and cell lysate was supplemented with 100X Halt Protease and
Phosphatase inhibitor single-use cocktail (Thermo Fisher Scientific, Waltham, MA, USA).
Epinephrine was measured in supernatants and cell lysate with a commercially available
Adrenaline/Epinephrine ELISA kit (Cat. No. E4359, BioVision Inc., Milpitas, CA, USA).
Neutrophil viability when challenged with Aa was determined by Trypan Blue
exclusion and cytospin microscopy imaging. For Trypan Blue exclusion neutrophils were
diluted 1:20 in Trypan blue at 0h, 4h, 8h and 24h and live cells were counted using a
hemacytometer. For cytospin images, cells were centrifuge at 6,000 xg for 30 secs and
wash twice with RPMI-1640 (no phenol red, Sigma-Aldrich, St. Louis, MO, USA) to
remove bacteria. Neutrophils were resuspended at 1 x 105 cells in 200µl of RPMI-1640
and added 5µl of human serum (Atlanta Biologicals, Flowery Branch, GA, USA). The cell
suspension was loaded into the funnel chamber that is assembled on the cytocentrifuge
clip, with slide and filter. Cytocentrifuge clip was centrifuge for 5 mins at 800 rpm
(Shandon Cytospin 3, Thermo Fisher Scientific, Waltham, MA, USA). The microscope
slide was removed from cytocentrifuge clip and fixed and stained using the Hema 3
Protocol staining kit (Thermo Fisher Scientific, Waltham, MA, USA). Slides were
visualized by light microscopy.
Lactate Dehydrogenase Assay
The CytoTox 96 non-radioactive cytotoxicity assay (Promega, Madison, Wisconsin
USA) was used to measure neutrophils cytotoxicity when challenged with Aa strains.
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Briefly, positive control was prepared by exposing 1 million neutrophils to 1% Triton X
and incubated for 2 hrs in the water bath at 37˚C. Following, the supernatant was collected
after centrifuging at 6,000 xg for 30 secs at 23˚C. Samples were added in triplicates of 50µl
of each sample to a flat bottom 96 well plate. A volume of 50µl of CytoTox 96 Reagent
was added to each well, cover from light and incubated for 30 min at room temperature.
Reaction was stopped by adding 50µl of Stop Solution to each well. Absorbance was read
at 490 nm within 1 hr after adding Stop Solution. Cytotoxicity percentage was calculated
using the following equation:

% Cytotoxicity = 100(

!"#$%&'$()*+ -./ 0$+$*1$23$4&5+$ -./ 0$+$*1$
6*" -./ 0$+$*1$

)

Determination of membrane integrity of neutrophils when challenged with A.
actinomycetemcomitans
Prior to neutrophil challenge, Aa was labeled with carboxyfluorescein
succinimidyl ester (CFSE) as follows: Bacteria were suspended in dH2O to 2x109 cfu/ml.
Equal volumes of CFSE (1 μg/ml) and bacteria in dH2O were mixed thoroughly, covered
with foil, and incubated at room temperature for 30 min on a rocker platform. Labeled
bacteria were washed twice with 1ml of 1XPBS and the optical density at 600nm (OD600)
of samples was measured. Subsequently, human neutrophils (4x 106 cells/ml) were
challenged with wild type (WT), or heat killed (HK) Aa (MOI 50) in suspension for 5, 15,
30 and 60 min at 37 ˚C with shaking in a water bath. Membrane integrity of neutrophils
was determined by two different methods: wheat germ agglutinin (WGA) membrane
labeling and TO-PRO-3 nuclear staining.
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WGA labeling of neutrophil membranes: After the bacterial challenge, samples
were added onto 24-well plates containing coverslips pre-treated with 50% of human serum
and centrifuged for 4 min at 600 xg with maximum braking. Supernatants were aspirated
and cells were fixed onto the coverslips with 4% paraformaldehyde (PFA) for 10 min,
followed by two washes of HBSS washes. Neutrophils were incubated with 5 µg/ml of
WGA (Life Technologies, Carlsbad, CA) Alexa Fluor 647 conjugate in HBSS for 10 min
at room temperature, then washed twice with PBS for 30 secs. Finally, cells were counterstained with DAPI (300 nM) for 5 min and then washed once with 500 µl 1XPBS for 5
min each at room temperature. Coverslips were mounted with 4 µl Prolong Gold Antifade
reagent and edges were sealed with clear nail polish. Slides were visualized using a
Fluoview FV1000 confocal microscope and analyzed by FV-10ASW software.
TO-PRO-3 staining of neutrophils nucleus: At each time point, 200 µl of each
sample was collected and placed on ice, protected from light. Collected samples were
centrifuged at 6,000 xg for 30 secs. Cells were fixed by resuspending in 200 µl of 4% PFA
and incubated for 10 min covered with foil at room temperature. Samples were washed by
centrifugation as before with PBS. Neutrophils were stained with TO-PRO-3 (1µM)
labeling solution in 1X PBS for 15 min at room temperature, protected from light.
Following, samples were washed once with 1X PBS and the resuspended in 200 µl of 1X
PBS and analyzed using flow cytometry imaging (AMNIS ImageStreamX MKII, Liminex,
Austin, TX).
Phagocytosis of A. actinomycetemcomitans by neutrophils visualized by confocal
microscopy
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Human neutrophils (4x 106 cells/ml) were challenged with WT Aa, HK Aa, JP2
ΔLtxA (MOI 50) or Fa (MOI 10) in suspension for 15, 30 and 60 min at 37 ˚C shaking in
a water bath. After challenge, cells were centrifuged at 6000 xg for 30 secs and resuspended
in 500 µl 1X PBS. This volume was then applied to pre-treated as before coverslips in a
24-well plate. The plate was centrifuged for 4 min at 600 xg at 14 ˚C. Supernatants were
aspirated, and cells were fixed cells using 4% PFA for 10 min. Supernatants were aspirated
and 200 µl of 3% BSA in PBS was added to each well for blocking. Then, plates were
incubated at room temperature for 1 hr on a slow rocker (if necessary, it was left at 4˚C
overnight) and the blocking solution was removed by aspiration. To stain extracellular Aa,
200 µl of mouse polyclonal anti-Aa (1 µg/ml) primary antibody in 3% BSA-PBS was added
to each well and incubated at room temperature for 1 hr on a slow rocker. Coverslips were
washed twice with 1X PBS then 200 µl of goat anti-mouse Alexa Fluor 647 (Cell Signaling,
Danvers, MA) secondary antibody in 3% BSA-PBS was added to each well. Plates were
incubated at room temperature for 1 hr on a slow rocker, followed by two washes with 1X
PBS. Antibody linkages were fixed by adding 200 µl of 4% PFA and incubating for 10
min. To stain internalized Aa, neutrophils were permeabilized with 3% BSA-PBS and
0.02% saponin and blocked by adding 200 µl of 3% BSA in PBS with 0.02% saponin.
Plates were incubated at room temperature for 1 hr on a slow rocker. After aspiration, 200
µl of mouse anti-Aa primary antibody in 3% BSA-PBS with 0.02% saponin was added to
each well. Plate was incubated at room temperature for 1 hr on a slow rocker and washed
twice with 1X PBS. Following, wash was aspirated and 200 µl of goat anti-mouse Alexa
Fluor 488 (Cell Signaling, Danvers, MA) secondary antibody in 3% BSA-PBS with 0.02%
saponin was added to each well. Plates were incubated at room temperature for 1 hr on a
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slow rocker and washed twice with 1X PBS. For nuclear staining we used DAPI at a final
concentration of 300 nM for 5 min and washed twice with 500 µl 1X PBS for 5 min each
at room temperature. Fixed coverslips were mounted with 4 µl of Prolong Gold Antifade
reagent. The edges of coverslips were sealed with clear nail polish. Slides were visualized
and Z-stack images were taken using the Leica TCS SP8 MP Confocal Microscope. Image
analysis was done using LAS X software. Quantification was performed by counting the
total viable and nonviable bacteria both intracellularly and extracellularly from 100
neutrophils in 3 independent experiments.
Measurement of Siglec-9 expression on human neutrophils by flow cytometry
Human neutrophils (4x 106 cells/ml) were challenged with WT Aa (MOI 50), Fa
(MOI 10) or Ps (MOI 10) in suspension for 2 hrs at 37˚C shaking in a water bath. After
challenge, 200 µl of each sample was collected and transferred into newly labeled tubes,
0.5 µl of Fc block was added and incubated on ice for 15 mins. Subsequently, Human
Siglec-9 PE conjugated antibody (10 µl/106 cells, Biotechne FAB1139P-100, Minneapolis,
MN) was added to each sample and incubated covered on ice for 1hr. As a control,
additional samples were stained with Mouse Ig2A PE conjugated antibody isotype control
(20 µl/106 cells, Biotechne IC003P, Minneapolis, MN), washed twice with 0.05% sodium
azide and fixed by resuspending in 1% PFA. Samples were run using a BD FACSCelesta
Flow cytometer and analyzed with FlowJo software.
Catecholamine Metabolism enzyme-linked immunosorbent assay (ELISA)
Cell lysates collected from neutrophils challenged with Aa at 2h, 4h, 8h and 24h
were tested for the presence of enzymes involved in catecholamine metabolism. The levels
of tyrosine hydroxylase (Cat. No. NBP3-06920, Novus Biologicals, CO, USA), dopamine
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b-hydroxylase (Cat. No. NBP2-67945, Novus Biologicals, CO, USA), catechol-omethyltransferase (Cat. No. OKBB00966, Aviva Systems Biology Corp., San Diego, CA,
USA) and monoamine oxidase-A (Cat. No. OKEH02825, Aviva Systems Biology Corp.,
San Diego, CA, USA) were measured following the indicated protocols supplied by the kit
manufacturer.
Neutrophil granule exocytosis and exocytosis inhibition
Neutrophils (4 × 106 cells/ml) were challenged with fMLF (300 nM, 5 min),
latrunculin A (1 μM, 30 min) + fMLF (300 nM, 5 min), or Aa at various time points from
5 min to 24h at 37°C in a shaking water bath. The exocytosis of secretory vesicles, specific
granules and azurophilic granules was determined by measuring the plasma membrane
increase of granule markers using fluorescein isothiocyanate (FITC)-conjugated anti-CD63
(for azurophilic granules, Ancell 215-040, Stillwater, MN, USA), FITC-conjugated antiCD66b (for specific granules, Biolegend 305104, San Diego, CA, USA), and
phycoerythrin (PE)-conjugated anti-CD35 (for secretory vesicles, Biolegend 333406, San
Diego, CA, USA) by FACSCalibur flow cytometer as previously described (McLeish,
2013 #1148;Uriarte, 2011 #212). Following antibody incubation, cells were washed with
0.5% sodium azide (S2002, Sigma, St. Louis, MO, USA) in FTA buffer (211248 BD,
Franklin Lakes, NJ, USA) and fixed with 1% paraformaldehyde (PX0055-3, EMD,
Darmstadt, Germany). Gelatinase granule exocytosis was determined by measuring the
release of matrix metallopeptidase 9 (MMP-9) by ELISA (Cat. No. ab100610, Abcam,
Cambridge, MA, USA). TAT-SNAP23 and TAT-Syntaxin 4 were used to inhibit
neutrophil granule exocytosis as previously described by Uriarte et al (Uriarte, 2011 #212)
and McLeish et al (McLeish, 2013 #631). Briefly, neutrophils (4 × 106 cells/ml) were
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pretreated with TAT-Syntaxin 4 (0.8 μg/ml), TAT-SNAP23 (0.8 μg/ml) or TAT-control (1
μg/ml) for 15 mins, followed by challenged with Aa for 15min, 2h, 4h and 8h at 37°C in a
shaking water bath. Granule exocytosis was measured by increase plasma membrane
expression of CD35 (secretory vesicles), CD66b (specific granules), CD63 (azurophilic
granules) by flow cytometry as described in previous paragraph. In addition, cell
supernatants were collected to measure release of secretory vesicle content by ELISA for
albumin (Cat. No. EHALB, Invitrogen, Thermo Fisher Scientific, Waltham, MA, USA),
gelatinase content by ELISA for MMP-9, specific granule content by ELISA for lactoferrin
(Cat. No. ab108882, Abcam, Cambridge, MA, USA) and azurophilic granule content by
ELISA for myeloperoxidase (Cat. No. ab119605, Abcam, Cambridge, MA, USA).
Recombinant epinephrine interaction with A. actinomycetemcomitans
Increasing colony forming units (CFUs) of Aa (0.0 - 4.0 x 108 CFUs) were
incubated with 250 pg/ml of recombinant epinephrine (BioVision Inc., Milpitas, CA, USA)
for 15 mins at 37°C in a shaking water bath. As a control, wells with epinephrine alone
were run in parallel. Samples were centrifuged at 6,000 xg for 5 minutes and supernatants
were collected. Immediately after, epinephrine was measured from supernatants with a
commercially available Adrenaline/Epinephrine ELISA kit (Cat. No. E4359, BioVision
Inc., Milpitas, CA, USA). For analysis, interpolated values were obtained from
recombinant epinephrine standard curve, following manufacturer instructions. The amount
of epinephrine associated with Aa was determined by subtracting the interpolated values
bacteria-containing of wells from the values obtained for control wells.
Epinephrine interaction with A. actinomycetemcomitans mutant strains
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Mutant strains of Aa (DqseC, qseCDpr and DqseC-comp, DygiW, DfepA) were
incubated at 3.0 x 107 CFUs with increasing concentrations (0 - 500 pg/ml) of recombinant
epinephrine (BioVision Inc., Milpitas, CA, USA) for 15 mins at 37°C in a shaking water
bath. Wells containing increasing concentrations of recombinant epinephrine served as
control. Following, samples were centrifuged as above, and supernatants were collected.
Immediately after, epinephrine was measured and analyzed as described above. The
amount of epinephrine associated with Aa was determined by subtracting the interpolated
values of Aa containing wells from the values of epinephrine control.
A. actinomycetemcomitans growth kinetics
Aa wild type was inoculated into BHI broth supplemented with bacitracin (50
µg/ml) and vancomycin (50 µg/ml) and grown under microaerophilic conditions at 37°C
to OD600 of 0.3 – 0.4. Cells were subcultured in fresh BHI broth at a 1:30 dilution and
grown as described above to an OD600 of 0.5–0.6. Cells were washed with chemically
define media (CDM, Table 2.3) and inoculated into CDM supplemented as above at a 1:30
dilution. Cultures were supplemented individually or with a combination of 100 µM FeCl2,
50 µM epinephrine, supernatant or cell lysate collected from neutrophils stimulated with
latrunculin A and fMLF (final epinephrine concentration of 30 pg/ml). The OD600 was
measured at various time points using a Bio- Rad SmartSpec Plus uV-vis
spectrophotometer (Bio-Rad, Hercules, CA, USA).
b-galactosidase assay
Quantitative evaluation of β-galactosidase activity was determined using
permeabilized cells incubated with o-nitrophenyl-b-D-galactopyranoside (ONPG)
substrate (Sigma, St Louis, MO, USA) as previously described (Miller, 1972 #632).
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Briefly, a primary culture of Aa (pDJR29) was grown at 37°C under microaerophilic
conditions in a closed tube overnight in BHI broth. The culture was subcultured at a 1:30
dilution in BHI broth and grown as described in the previous paragraph for 24h.
Subsequently, the secondary overnight culture (OD600 of 0.3–0.4) was diluted 1:30 into
CDM and grown in an anaerobic chamber for 24 h at 37°C. An aliquot of 0.1 ml was then
used to determine the OD600 of the culture at 24h and triplicate aliquots of 0.1 ml were used
to measure β-galactosidase activity.
Expression and isolation of QseC and YgiW proteins
E. coli BL21 (DE3) strains (Table 2.1) containing the pDJR1 QseC and pDJR3
YgiW constructs (Table 2.2) were grown in Luria broth (LB, Difco, BD Biosciences,
Franklin Lakes, NJ, USA), supplemented with respective antibiotics (1:103) with shaking
at 37˚C for 2-3 hrs. Cultures were then diluted to initial OD600 of 0.1 in LB and incubated
until an OD600 of 0.6 was attained. Following, isopropyl-β-D-1-thiogalactopyranoside
(IPTG) was added to a final concentration of 1mM and incubated to induce protein
expression. At 4hrs post-supplementation with IPTG, 1mL aliquots of E. coli cultures were
used to measure OD600. Cultures were centrifuged (4,000 xg for 20 minutes at 4°C) and
supernatant was discarded. Following, pellets were resuspended in Lysis Buffer NTI-10-G
(Thermo Fisher Scientific, Waltham, MA, USA), then centrifuged as before and
supernatant was collected and transferred to a new tube as the soluble fraction. To obtain
the insoluble fraction, pellets were resuspended in lysis buffer containing lysozyme,
benzonase nuclease and n-dodecyl-β-D-maltoside (DDM). Cells were disrupted using
sonication, centrifuged (20,000 xg for 1 hr at 4°C) and supernatant was collected as the
insoluble fraction.
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Visualization and quantification of QseC and YgiW proteins
Proteins QseC-pr and YgiW were expressed as GST and HIS fusion protein
respectively. Approximately 1 µg of protein of each fraction was loaded on a NuPAGE
Novex 4-12% Bis-Tris Protein gel (ThermoFisher, Waltham, MA) and electrophoresed for
30 minutes at 200V. The gel was stained for one hour with shaking with AquaStain
(Bulldog Bio, Portsmouth, NH), then 1hr with dH2O. Protein bands from PAGE gel were
transferred into a PVDF membrane by western blot. QseC-pr was detected using a primary
antibody rabbit anti-GST (ThermoFisher, Waltham, MA) and a secondary antibody antirabbit-HRP (Cell Signaling, Danvers, MA). To detect YgiW, we used a primary antibody
mouse 6X-HIS Monoclonal (CloneTech, Mountainview, CA) and a secondary antibody
anti-mouse-HRP (Cell Signaling, Danvers, MA). Crude samples corresponding to QseCpr were bound to a GraviTrap GST Column (Sigma, St. Louis, MO) or those corresponding
to YgiW were bound to a His60 Ni Gravity Column Set (Takara Bio USA) and eluted with
elution buffer provided with manufacture’s kit materials. The fractions containing the
appropriate bands identified by SDS-PAGE and western blot using the previously
described antibodies. Protein concentration was obtained by NanoDrop One
Spectrophotometer (ThermoFisher, Waltham, MA).
Microdialysis assay of QseC or YgiW interaction with Cat-Fe
Interaction of QseC and YgiW with epinephrine or iron was done using Micro
Dialyzer (Harvard Apparatus) equilibrium two chamber systems with cellulose
membranes. A fixed concentration of epinephrine (50 μM) or iron (100 μM) was added to
one chamber and the same concentration of protein was added to the second chamber.
Dialysis was left to reach equilibrium for 24hrs. A sample was collected from each chamber

38

and the presence of iron or epinephrine was measured using Iron colorimetric assay
(BioVision, San Francisco, CA) and Adrenaline/epinephrine ELISA (BioVision, San
Francisco, CA).
Construction of ΔfepA complement
Cultures of XL1 E.coli containing the pJT3 plasmid (Table 2.1, Figure 2.1) were
grown overnight. Plasmid was isolated using the Plasmid Miniprep kit (Qiagen, USA) and
plasmid concentration was determined using the NanoDrop One (ThermoFisher, Waltham,
MA). Isolated plasmid was first digested with BamHI-XbaI (New England BioLabs,
Ipswich, MA) to remove the lacZ region. The digested sample was run on an agarose gel
and the upper band (~5.8kb) was extracted from the gel using the Qiagen QIAquick gel
extraction kit (Qiagen, USA) and cleaned with Zymo Research DNA Clean and
Concentrator Kit (Irvine, CA). Using Aa chromosomal DNA as a template, the tonB gene
was PCR amplified using a high fidelity Taq polymerase (Invitrogen, Waltham, MA) and
primer set: WW175 and WW176, respectively. The primers were flanked with restriction
sites as shown in Table 2.2. The PCR product was visualized on a 1% agarose gel, excised,
and digested with BamHI-XbaI. Following, the PCR fragment was cleaned using Zymo
Research DNA Clean and Concentrator Kit. The pJT3 BamHI-XbaI fragment was ligated
into the digested PCR product (tonB) BamHI-XbaI to make pJT3/tonB plasmid. The ptrC
promoter region was amplified from pJT1 plasmid (Table 2.1, Figure 2.1) DNA using the
primer set WW86 and WW87 (Table 2.2), digested with KpnI-BamHI, cleaned with Zymo
Research DNA Clean and Concentrator Kit. The ptrC promoter region was ligated into the
pJT3/tonB fragment to make the pJT3/tonB/ptrC plasmid. The ligation reaction was
transformed into XL1 blue E.coli cells by electroporation at 100V for 30 minutes and
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incubated for 1 hour in SOC medium (2% tryptone, 0.5% yeast extract, 10 mM NaCl, 2.5
mM KCl, 10 mM MgCl2, 10 mM MgSO4, and 20 mM glucose) with shaking. Aliquots of
50 μl were then plated on LB agar plates supplemented with 50 μg/mL of tetracycline and
25 μg/mL kanamycin and incubated overnight. Colonies were collected and cultured in
BHI, plasmid was extracted using the Plasmid Miniprep Kit (Qiagen, Germany) and
confirmed by sequencing using the University of Louisville Sequencing Core to confirm
correct insertion. After confirmation, 25 μg of plasmid was transformed into Aa 652 by
electroporation. Transformed cells were cultured on BHI plates supplemented with
kanamycin and resulting colonies were selected for plasmid purification, digestion with
BamHI-XbaI followed by digestion with KpnI. Digestion sample was run in a 1% agarose
gel with the same conditions as before. The presence of three bands 2.4kb (pJT1 without
sacB) of 2.1kb (tonb) and 81bp (ptrC)).
Construction of ΔfepA-expressing the pDJR29 plasmid
Cultures of XL1 E.coli containing the pDJR29 plasmid (Table 2.1) were grown
overnight as previously described. Plasmid was isolated using the Plasmid Miniprep kit
(Qiagen, USA) and plasmid concentration was determined with a NanoDrop One
(ThermoFisher, Waltham, MA). Following, 25 μg of plasmid was transformed into Aa 652
by electroporation. Transformed cells were cultured on BHI plates supplemented with
kanamycin and resulting colonies were selected for plasmid purification. To confirm the
plasmid insertion, plasmid was digested with BamHI-XbaI (New England BioLabs,
Ipswich, MA) and ran on an agarose gel.
Statistical Analysis
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Unless otherwise noted, statistical experimental conditions and time points were
analyzed by an ordinary one-way ANOVA, followed by post hoc Tukey’s multicomparison test using GraphPad Prism Software (GraphPad PRISM v9, San Diego, CA,
USA). Differences were considered significant at P < 0.05.
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Table 2.1. Strains and plasmids used in this project
Strain or plasmid

Derived/characteristics*

Source/Reference

A. actinomycetemcomitans

652

Wild type, serotype c (Vancor, Bacir)

Laboratory stock

652-JR23

qseCΔpr (135)

(92)

652-JR38

ΔqseC (135)

(92)

652-JR38

ΔqseC-comp (135)

(92)

652-JR25

ΔygiW (135)

(92)

652(pDJR29)

ygiW-qseBC promoter -1 to -372-lacZ (Kmr)

(200)

652(ΔfepA)

ΔfepA(135)

(204)

652(ΔfepA-comp)

ΔfepA-comp(135)

This study
r

652(ΔfepA/pDJR29)

ΔfepA, ygiW-qseBC promoter -1 to -372-lacZ (Km )

This study

JP2

Wild type, serotype b, highly leukotoxic strain

(205)

JP2 (ΔLtxA)

Gene deletion mutation

DR Demuth, unpublished
E. coli

-

E. coli BL21
E. coli XL1

-

-

(DE3 ompT hsdSB(rB mB )gal dcm rne131
BL21(DE3)
Δ(mcrA)183 Δ(mcrCB-hsdSMR-mrr)173
endA1 supE44 thi-1 recA1 gyrA96 relA1 lac
[F proAB. lacIqZΔM15 Tn10 (Tcr)]

Novagen
Stratagene

Other strains used

F. alocis

Wild type

P. stomatis

Wild type

ATCC
(202)
Plasmids

pJT1

Spr; suicide vector

pJT3

Kmr; pYGK*, promoterless lacZ reporter vector

(200)
r

(200)

pDJR29

pJT3, PygiW372-lacZ (Km )

(92)

pDJR1

Ampr; pGEX-4T-1; GST : : qseC periplasmic region

(92)

r

pDJR3
Km ; pET28a+ygiW-AU1-66His
(92)
*
Vancor – vancomycin resistance, Bacir – bacitracin resistance, Kmr - kanamycin resistance, Spr spectinomycin resistance, Ampr – ampicillin resistance
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Table 2.2. Primers used in this project
Primer

Description

Sequence

WW86

ptrC F

GCGCTTATTGCTGGTACCATTCTGAAATGAGCTG

WW87

ptrC R

CATAGATCTGGATCCCATTTTCCTGTGTGAAATTGTTATCC

WW175

tonB receptor

CAAGGACGTACCATGGGATCCAAAAAACTC

complement F
WW176

tonB receptor

GCACTTTCTTATATCATTCATCTAGATTAGAAACTGTATTTCAG

complement R
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Source

(204)

Table 2.3. Composition of chemically defined media (CDM)
Amino Acid Stock
Hydrophilic Amino Acids

Hydrophobic Amino Acids

Purine/Pyrimidine

L-cystine

10mL

H2O

15mL

H2O

10mL

H2O

5mL

H2O

2.5mL

2M NaOH

3.125mL

2M NaOH

1.25mL

2M NaOH

0.625mL

2M NaOH

499.2mg

L-glutamic Acid

200mg

L-alanine

25mg

Adenine

10mg

L-cystine

200mg

Glycine

200mg

D-alanine

20mg

200mg

L-Threonine

200mg

L-leucine

27mg

200mg

200mg

L-valine

20mg

200mg

L-Tryptophan

20mg

Xanthine

200mg

L-methionine

20mg

Hypoxanthine

200mg

L-isoleucine

20mg

Uracil

200mg

L-Serine
L-lysine
hydrochloride
L-arginine
hydrochloride
L-histidine
hydrochloride
L-glutamine

Guanine
Cytosine
hydrochloride
Thymine

200mg

L-phenylalanine

227.2mg

L-asparagine

40mg

L-tyrosine

200mg

L-proline

200mg

L-aspartic acid
L-ornithine
hydrochloride
Lhydroxyproline

200mg
242mg
270.2mg

40mg
40mg

Combine hydrophobic, hydrophilic, purine & pyrimidine and L-cystine to make amino acid stock.
Inorganic Salt Stock

Vitamin Stock

Pimelic Acid/Biotin

1L CDM

99.5mL

H2O

20mL

H2O

5mL

H2O

10mL

10mg

MnSO4

1000mg

Choline chloride

5mL

Ethanol

50mL

200mg

NaCl

200mg

β-alanine

1mg

Pimelic Acid

50mL

400mg

K2HPO4

20mg

Pyridoxal

1mg

D-Biotin

1mL

2000mg

KH2PO4

20mg

Pyridoxine-HCl

Lipoamide

50mL

200mg

KNO3

20mg

0.1mg

KI

20mg

0.065mg

CuSO4:5H2O

20mg

0.5mg

Boric Acid

20mg

0.7mg

ZnSO4:7H2O

20mg

0.5mg

Sodium
molybdate

20mg

Thiamine-HCl

200mg
20mg
2mg
.00005mg

Pyridoxaminedi-HCl
Spermidine-triHCl
Nicotinic Acid

1mL

βmercaptoethanol

10mL

9mL

Ethanol

10mL

1mg

Lipoamide

1mL

Calcium
pantothenate
Spermine-tetraHCl

10mL

CaCl2
(10mg/mL)
Amino Acid
Stock
Inorganic
Salt Stock
Vitamin
Stock
NaHCO3
(20mg/mL)
Cysteine
(65mg/mL)
MgSO4
(70mg/mL)
Pimelic
acid/Biotin
Riboflavin
(0.1mg/mL)

Folic Acid

1mL

Lipoamide

9.975mL

H2O

1mL

Folic Acid

Myo-Inositol

25uL

NH4OH

NAD
p-aminobenzoic
acid
Vitamin B12

10mg

Folic Acid
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CHAPTER 3
TRIALS AND TRIBULATIONS: INTERACTIONS OF EPINEPHRINE WITH
COMPONENTS OF THE QSEBC TWO-COMPONENT SYSTEM
Introduction
Bacteria constantly assess their surroundings and make use of the information
acquired to regulate the expression of targeted genes for growth, survival, and virulence.
In turn, during infection, host cells have evolved mechanisms to limit microbial access to
necessary nutrients in the environment. For example, molecules like lactoferrin and
transferrin are known to be released by leukocytes to sequester iron, making it unavailable
to bacteria (124). However, bacteria have evolved sensing mechanisms involving twocomponent regulatory systems (TCS) to survey their environment and regulate the
expression of genes required to adapt accordingly. In general, these systems consist of two
components, as the name entails, a sensor and a response regulator protein. The kinase
domain of the sensor protein phosphorylates the response regulator, which in turn will act
as a DNA binding protein and transcription factor, promoting or inhibiting gene regulation.
Aa encodes the QseBC (quorum sensing in E. coli) TCS, highly conserved in
Enterobacteriaceae and the Pasteurellaceae, and present in organisms such as E. coli (206,
207), S. Typhimurium (158, 208, 209). The qseBC operon encodes the genes for QseC, a
sensor kinase, and QseB, a response regulator (88). The qseBC operon in Aa exhibits 70%
nucleotide similarity to E.coli qseBC, however this operon is organized differently in Aa.
A third gene is also found in the qseBC operon, ygiW, it encodes a periplasmic solute
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binding protein in the OB fold family of proteins (159, 160). Real time PCR of qseB, qseC
and ygiW in Aa, showed that all three genes were transcribed in a primary transcript (92).
Promoter mapping (Figure 3.1) supported this by indicating that the ygiW gene resides
upstream of qseBC and that an attenuator region is found between ygiW and qseBC (92,
153). Although, YgiW mechanisms or functions remain unknown, knockout of the ygiW
gene resulted in increased biofilm biomass (88, 92). Interestingly, decreased biofilm
growth was observed after an in-frame deletion of the periplasmic domain of QseC (QseCpr) in Aa (92). The opposing effects of these genes deletions, suggest that two independent
signals are recognized by YgiW and QseC to control biofilm formation (92). Furthermore,
deletion of the qseB gene in Aa demonstrated that a functional QseB protein is necessary
for the expression of the ygiW-qseBC operon, suggesting that qseBC is auto-regulated (92).
Previous work demonstrated that QseBC is activated by catecholamine hormones
and iron, and induces the expression of genes associated with anaerobic metabolism and
respiration (91). Similar to Bordetella, Aa does not express siderophores to sequester
nutrients such as iron (141) but instead uses catecholamines from the host to scavenge for
iron (210), and catecholamines are recognized by a siderophore receptor on its membrane
(137-140). Microarray data of Aa grown in chemically defined media (CDM)
supplemented with epinephrine and iron showed genes involved in iron uptake were
downregulated in a QseBC dependent manner, but the expression of the enterobactin (ent)
operon remained unchanged (91). This enterobactin operon (Figure 3.2) in Aa consists of
four open reading frames (ORFs) encoding the ABC transporter, a permease, periplasmic
– binding proteins and FepA, an enterobactin/siderophore receptor (142). These
observations suggest that Aa may exploit the catecholamine rich environment in the sub
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gingival pocket to acquire iron in the host environment. For example, catecholamines
released by neutrophils may function as pseudo-siderophores and sequester iron from the
environment or from iron binding proteins such as lactoferrin. Subsequently,
catecholamines may be bound by the Aa enterobactin receptor or other cell receptors for
transport which may result in activation of QseBC. To further explore this hypothesis, in
this chapter we describe optimized protocols for expression and isolation of the periplasmic
domain of the sensor protein QseC and the periplasmic solute binding protein YgiW and
approaches utilized to determine the interactions of these proteins with epinephrine and/or
iron.
Results
YgiW is not required for A. actinomycetemcomitans to interact with epinephrine
Previous work in our lab demonstrated that QseBC was required for Aa biofilm
growth and virulence (88) and that the periplasmic domain of QseC was required for
activation of the TCS by catecholamines and iron (91). Further, we recently demonstrated
that QseC and QseC-pr are required for Aa to interact with epinephrine (210). To determine
if YgiW is required for Aa to interact with epinephrine, we performed epinephrine
interaction assays using Aa DygiW strain (3.0 x 107 CFUs) with increasing concentrations
(0 - 500 pg/ml) of recombinant epinephrine for 15 mins at 37°C in a shaking water bath.
As a control, wells with only increasing concentrations of recombinant epinephrine were
used. Epinephrine levels were measured by ELISA. We show that the epinephrine
interaction of Aa DygiW was not different to that of wild type Aa (Figure 3.3). This suggests
that YgiW is not required for Aa to interact with epinephrine.
FepA plays a role in the interaction of A. actinomycetemcomitans with epinephrine
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Microarray data from our lab showed that expression of the genes in the enterobactin
operon remained unchanged in the presence or absence of Cat-Fe (91). The ent operon in
Aa is composed of the ABC transporter, permease, periplasmic-binding proteins and the
enterobactin receptor FepA (D11S_1354) (141). Since Aa does not produce enterobactin
to sequester iron, FepA was considered a potential receptor for Epi-Fe (91). We
hypothesized that FepA interacts with Epi-Fe from the host environment and transports
iron using its ABC transporter. To test this hypothesis, we performed an epinephrine
interaction assay as described above and compared Aa to heat killed Aa and an Aa strain
deficient in FepA (DfepA). Interaction of epinephrine was significantly decreased by
deletion of the fepA gene compared to wild type Aa (Figure 3.4, p = 0.0312). Interestingly,
heat killed Aa 652 interaction with epinephrine was significantly decreased compared to
live bacteria (Figure 3.4, p = 0.0078), suggesting that heat treatment may denature or
inactivate FepA. Further, transportation through FepA is TonB energy dependent (91),
which requires viable bacteria. These observations suggest that FepA interacts with
epinephrine, but because this interaction was not completely ablated, our results suggest
that epinephrine may interact with other adrenergic receptors. Further studies are needed
for the identification of the potential receptors.
Discussion
Weigel et al. (91) identified catecholamine (epinephrine/norepinephrine) and iron
as the signal detected by QseC and required to induce the qseBC operon. As initial
experiments to further characterize this interaction, we performed equilibrium dialysis
experiments with only epinephrine or iron only in MOPS buffer. However, when trying to
establish optimal microdialysis conditions, we faced with numerous obstacles, such as high
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levels of background in the control reactions. For this reason, we approached the problem
from another angle, where different Aa strains were incubated with recombinant
epinephrine. Recently we demonstrated that QseC and QseC-pr are required for Aa to
interact with epinephrine (210). Conversely, the interaction of epinephrine with Aa ΔygiW
was not different to that of wild type (Figure 5.5). These results show that Aa interaction
with epinephrine occurs independently of YgiW expression. YgiW is a member of the
bacterial oligonucleotide/oligosaccharide-binding (OB)-fold (BOF) family. Their structure
consists of five antiparallel β-sheets that form a closed or partially opened barrel-like
structure, allowing them to act as scaffolds in ligand binding (160). Although, little
characterization of BOF proteins exist, these proteins have been linked to stress responses
(161, 162). CusF, a BOF protein was shown to bind copper and serve as a shuttle of copper
to an efflux system, increasing the accessibility of copper in the periplasmic space (211).
While we do not fully understand the role of YgiW in Aa at this time, is likely that Aa
shares similarities in metal binding with other BOF proteins involved in stress responses
and be involved in metal binding, but this requires further exploration.
Microarray data from our lab showed that genes found in the enterobactin operon,
including the enterobactin receptor FepA remained unchanged in the presence or absence
of Cat-Fe while iron uptake genes were downregulated upon QseBC activation (91). We
tested an Aa mutant strain of FepA (ΔfepA) to determine if FepA is required for Aa
interaction with epinephrine. We found that the interaction of epinephrine was decreased
in the ΔfepA strain compared to wild type, suggesting that FepA interacts with epinephrine.
Similarly, heat killed Aa interaction with epinephrine decreased, suggesting that heat
treatment may denature or inactivate FepA. Aa is particularly heat sensitive and by

50

increasing the temperature to 650C for 5 mins, proteins such as FepA and the TonB energy
system required for transport through FepA may be denatured. The interaction of Aa with
epinephrine was not completely inhibited in the ΔfepA strain, suggesting that FepA may
not be the sole transport system for Cat-Fe in Aa. A potential alternative mechanism for Aa
to acquire iron at low oxygen levels is the Feo iron transport system (145, 146, 212), which
does not require TonB. However, it is not known if the Feo system can transport
catecholamines. Further investigation is required to identify potential players.
In this chapter we show that Aa interaction with epinephrine requires FepA and not
YgiW, contributing to previous findings were QseC and QseC-pr were shown to be
required for this interaction. In conclusion, our results suggest that epinephrine interacts
with FepA on the bacterial membrane. Furthermore, if YgiW shares function with other
BOF proteins, it is possible that it may interact with iron in the periplasmic space and
transport it to QseC, thus activating the TCS.
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Figure 3.1. Structure of the ygiW-qseBC operon in Aa, modified from Juarez-Rodriguez et
al. (92)
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Figure 3.2. Structure of the enterobactin operon in Aa, based on D11S_13541357 (Kegg Genome Database).

53

Figure 3.3. YgiW is not required for A. actinomycetemcomitans interaction with
epinephrine. Aa (DygiW) was incubated at 3.0 x 107 CFUs with increasing concentrations

(0 - 500 pg/ml) of recombinant epinephrine for 15 mins at 37°C in a shaking water bath.
As a control, wells with only increasing concentrations of recombinant epinephrine were
used. Epinephrine levels were measured by ELISA. The amount of epinephrine associated
with Aa was determined by subtracting the interpolated values of Aa containing wells from
the values of epinephrine control. The mean epinephrine concentration was plotted with
standard error bars. Statistical differences among experimental conditions were analyzed
by two-way ANOVA, followed by Tukey’s post-test. ns = not significant.
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Figure 3.4. FepA is required for A. actinomycetemcomitans interaction with epinephrine.

Aa (DfepA) was incubated at 3.0 x 107 CFUs with increasing concentrations (0 - 500 pg/ml)
of recombinant epinephrine for 15 mins at 37°C in a shaking water bath. As a control, wells
with only increasing concentrations of recombinant epinephrine were used. Epinephrine
levels were measured by ELISA. The amount of epinephrine associated with Aa was
determined by subtracting the interpolated values of Aa containing wells from the values
of epinephrine control. The mean epinephrine concentration was plotted with standard
error bars. Epinephrine levels were measured by ELISA and plotted as the mean ± SD of 5
independent experiments. Statistical differences among experimental conditions were
analyzed by two-way ANOVA, followed by Tukey’s post-test. *p < 0.05, **p < 0.01.
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CHAPTER 4
THE HUNGER GAMES:
AGGREGATIBACTER ACTINOMYCETEMCOMITANS EXPLOITS HUMAN
NEUTROPHILS AS AN EPINEPHRINE SOURCE FOR SURVIVAL
*This chapter has been modified from recent publication Ozuna et al. (210)
Introduction
In the oral cavity, when host microbe homeostasis is broken, bacterial communities
accumulate at the sub-gingival pocket and form biofilms that lead to oral diseases such as
periodontitis (3). Periodontitis consists of a chronic inflammation of the periodontium
caused by the inflammatory response of the host to plaque biofilm. The disease is
characterized by the progressive deepening of the sulcus and loss of attachment between
the bone and gingival tissue leading to bone loss. Recurring inflammation of the
periodontium has been associated with the initiation, exacerbation, and pathogenesis of
several other inflammatory diseases (213). Aa is a non-motile Gram-negative facultative
anaerobe of the Pasteurellaceae family (34, 214, 215). Aa has been strongly associated
with periodontitis and other diseases such as rheumatoid arthritis, cardiovascular diseases,
atherosclerosis, urinary tract infections and brain abscesses (93-96). Aa contributes to
tissue inflammation, destruction, and bone resorption by expressing several virulence
factors such as cytolethal distending toxin, leukotoxin A of the RTX family of bacterial
toxins and collagenase (97, 112, 117, 216).
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In the subgingival pocket Aa must compete for nutrients, such as iron, to survive. As
part of the host immune response iron is kept unavailable to bacteria by being sequestered
by catecholamines (i.e. stress hormones: epinephrine, norepinephrine and dopamine) or
leukocyte-produced molecules like lactoferrin and transferrin (154, 168). However, some
bacteria have evolved to subvert this mechanism by producing iron scavenging molecules,
known as siderophores (132, 147, 212) or using host-derived catecholamines (154). Stress
is considered as an essential factor in development and progression of periodontal disease
(217-219). Further, catecholamine stress hormones have been not only detected in saliva
of periodontitis patients but is has been shown to increase under stress (220, 221).
Catecholamines have been implicated as causative or contributory agents of periodontitis
(174, 222, 223). Interestingly, Aa does not produce siderophores (141), but expresses the
QseBC (quorum sensing in Escherichia coli) two-component system (TCS) that is
activated in the presence of both catecholamines and iron (91). Two component systems
are phosphorelay systems that sense an outer cell signal that will then translate into
regulation of targeted genes inside the cell (150-152). This system consists of two
components, as the name entails, a sensor and a response regulator protein. The sensor
protein is a histidine kinase (HK) homodimer which sensor domain sits on the inner
membrane. The kinase domain of the HK phosphorylates the response regulator which in
turn will act as a DNA binding protein or transcription factor, promoting gene regulation.
The qseBC operon, encodes the genes for qseC, a sensor molecule and qseB, the response
regulator (92). Novak et al (88), demonstrated the requirement of QseC for Aa biofilm
growth and virulence. Further, Weigel et al. (91), subsequently showed that Aa growth in
a chemically define media (CDM) supplemented with both epinephrine or norepinephrine
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and ferrous (Fe2+) or ferric (Fe3+) iron increased qseBC promoter activity and bacterial
growth, indicating that both catecholamines and iron are required for the activation of
QseBC. Additionally, microarray analysis showed that activation of QseBC induced the
expression of genes associated with anaerobic metabolism and respiration, and reduced
expression of genes involved in iron uptake and transport. However, the source of
catecholamines remained to be determined.
The recent field of microbial endocrinology studies the interkingdom signaling that
exists between microbe and host because of coexistence (171). Microbes have evolved
systems to detect or sense host-associated signals such as stress hormones (168). This
allows them to scan their environment and regulate required genes (167, 169-173). In
periodontitis neutrophils are found in large numbers at the gingival crevice (35). Murine
neutrophils have been shown to release epinephrine or norepinephrine when stimulated
with LPS (166). Furthermore, increased levels of the enzymes (tyrosine hydroxylase and
dopamine β-hydroxylase) required for the synthesis of catecholamines, and their
inactivation (catecholamine-O-methyltransferase and monoamine oxidase) enzymes has
been observed in murine phagocytes and human lymphocytes (166, 224). Nonetheless, the
presence of catecholamines in the host environment has also been shown to promote
bacterial iron uptake and growth in media limited conditions (154, 174, 223). Host-derived
catecholamines have a higher affinity to iron than antimicrobials like lactoferrin and
transferrin (154, 178) serving as excellent pseudo-siderophores (175) to bacteria.
Therefore, we proposed that human neutrophils serve as a catecholamine source for Aa to
sequester iron, leading to QseBC activation and bacterial growth.
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In this chapter we demonstrate that human neutrophils have significant levels of
tyrosine hydroxylase, monoamine oxidase A and catecholamine-O-methyltransferase,
validating that neutrophils participate in catecholamine metabolism. In addition, we present
evidence that human neutrophils store epinephrine in the azurophilic granules and that
interaction with Aa induces exocytosis of azurophilic granules and release of epinephrine.
Furthermore, we show that treatment with latrunculin A followed by fMLF stimulation,
which is known to induce mobilization and content release of azurophilic granules, induces
epinephrine release in human neutrophils. The interaction of released epinephrine with Aa
activates QseBC and induces Aa growth under anerobic conditions. These results suggest
that neutrophils may serve as an epinephrine source for Aa, to facilitate growth and prime
anaerobic metabolism in the subgingival pocket. The findings presented here help shed
light into the crosstalk that exits between bacteria and the host endocrine system by
providing an example of the role that stress hormones play in periodontal disease and
potentially other chronic inflammatory diseases.
Results
A. actinomycetemcomitans challenge induces epinephrine release, and promotes de novo
catecholamine synthesis in human neutrophils
It has been previously shown that murine neutrophils stimulated with LPS can release
catecholamines (166). As an initial study we replicated these findings and confirm that
LPS induced the release of epinephrine by murine neutrophils and that this release
increased with time (Figure 4.1.A). However, there is as of yet no clear evidence of human
neutrophils ability to release catecholamines. To determine if human neutrophils release
epinephrine, cells were stimulated with fMLF, latrunculin A + fMLF, LPS or IL-8.
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Supernatants and cell lysates were collected, and epinephrine levels determined by ELISA.
Unlike what was described in murine neutrophils (166), LPS stimulation did not induce
epinephrine release by human neutrophils (Figure 4.2.A) even at extended time points
(Figure 4.1.B). Similarly, stimulation of neutrophils with fMLF or IL-8 failed to induce
epinephrine release (Figure 4.2.A). Interestingly, treatment with latrunculin A followed by
fMLF induced significant release of epinephrine compared to fMLF alone and basal
(Figure 4.2.A). Significant levels of epinephrine were detected in the cell lysates but there
was no significant difference between experimental conditions (Figure 4.1.C, 4.2.B).
Following, we examined the ability of Aa to induce epinephrine release by human
neutrophils. Cells were challenged with Aa at a MOI of 50 in suspension for 2h, 4h, 8h and
24h. Epinephrine levels were measured from supernatants and cell lysates by ELISA.
Figure 1c shows that Aa challenge induced significant release of epinephrine compared to
basal, with maximum levels reached at 4h. Epinephrine levels in cell lysates of human
neutrophils treated with latrunculin A + fMLF had significantly reduced levels of
epinephrine compared to basal (Figure 4.2.D), this correlates the significant increase
release of epinephrine observed in supernatants (Figure 4.2.C). Similarly, low epinephrine
levels in neutrophil cell lysates were detected after challenged with Aa for 2h and 4h which
could be related to the release observed in the supernatants (Figure 4.2.C-D). Interestingly,
epinephrine release at 2h was similar to basal (Figure 4.2.C). A potential explanation for
this is that the released epinephrine could be interacting in some way with Aa. We repeated
this experiment with highly purified (>99%) human neutrophils (Figure 4.3) and obtained
similar results.
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To confirm that the release of epinephrine is not caused by a cytotoxic effect of Aa
on neutrophils we evaluated the morphology of human neutrophils with cytospin imaging
and viability with trypan blue exclusion. Human neutrophils morphology was not altered
with Aa challenge (Figure 4.4.A-B) and challenge with Aa extended the lifespan of
neutrophils (Figure 4.4.C) up to 24h. Taken together our results demonstrate that Aa
stimulates epinephrine release in human neutrophils, depleting storage reservoirs. In
addition, the difference in released (Figure 4.2.C) versus stored epinephrine at 2h (Figure
4.2.D) suggests that epinephrine may be interacting with Aa. The increase of epinephrine
levels in cell lysates at later time points of 8h and 24h (Figure 4.2.D) suggests that human
neutrophils are capable of de novo catecholamine synthesis.
Next, we examined the levels of enzymes involved in catecholamine metabolism.
Levels of enzymes involved in catecholamine synthesis: tyrosine hydroxylase and
dopamine β-hydroxylase and levels of enzymes involved in catecholamine inactivation:
catechol-o-methyltransferase and monoamine oxidase-A were measured in cell lysates of
human neutrophils exposed to Aa at 2h, 4h, 8h and 24h by ELISA. In the absence of Aa
tyrosine hydroxylase levels are significantly low but after Aa challenge levels increase
significantly with time compared to basal (Figure 4.5.A). In contrast, dopamine βhydroxylase levels decrease when Aa is present (Figure 4.5.B). The levels of catechol-omethyltransferase (Figure 4.5.C) and monoamine oxidase-A (Figure 4.5.D) remained
comparable to basal, only peaking at 4h. Catecholamine synthesis enzyme (tyrosine
hydroxylase levels) increase at 8h and 24h (Figure 4.5.A), whereas inactivation enzymes
(Figure 4.5.C-D) decrease at the same time points. These results indicate that Aa challenge
induces de novo catecholamine synthesis in human neutrophils.
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In the infected subgingival pocket Aa functions in consortium with other bacteria in
bacterial communities known as biofilms and Fine et al showed that Aa positive subjects
with bone loss had high levels of the oral pathogen Filifactor alocis (225). In addition,
Wang et al demonstrated that F. alocis accumulation in the oral biofilm was stimulated by
the present of specific strains of Aa (226). To examine if the induction of epinephrine
release is specific to Aa, we performed a time course experiment where we investigated the
ability of F. alocis to induce epinephrine release in human neutrophils. Human neutrophils
were challenged with F. alocis at a MOI of 10 at 1h, 2h and 4h incubation and epinephrine
detection were performed as described above. F. alocis failed to induce significant release
of epinephrine (Figure 4.6.A). Consistent with this, no significant difference in epinephrine
content was detected in cell lysates among experimental conditions (Figure 4.6.B). In
addition, human neutrophils were challenged with LPS up to 24h and no significant
epinephrine release or difference in epinephrine content was observed (Figure 4.6.C-D).
A. actinomycetemcomitans access epinephrine by inducing exocytosis of human neutrophil
granules
In Figure 4.1 we showed that treatment with latrunculin A followed by stimulation
with fMLF, which is known to induce the exocytosis of gelatinase and azurophilic granules,
induced epinephrine release by human neutrophils, suggesting that epinephrine may be
stored in one or more of the neutrophil granules. To demonstrate this, we first determined
the ability of Aa to induce granule exocytosis. Neutrophils were challenged with Aa and
granule exocytosis was determined by measuring increase of plasma membrane expression
of secretory vesicles, specific granules and azurophilic granule markers by flow cytometry
(see gating strategy and histograms Figure 4.7) and the extracellular release of MMP-9 by
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ELISA. Stimulation with Aa induced significant secretory vesicles mobilization by 15
mins, as indicated by increased CD35 expression (Figure 4.8.A) which was similar to the
exocytosis induced by the positive control fMLF. In addition, gelatinase granules
exocytosis, measured by ELISA, was significantly induced after 2h of Aa challenge (Figure
4.8.B). Specific granule exocytosis, measured by increased CD66b expression, was
significantly increased after 4h of Aa challenge (Figure 4.8.C). Azurophilic granule
exocytosis, measured by increased CD63 expression, was significantly increased starting
at 8h post bacterial challenge (Figure 4.8.D). Mobilization of azurophilic granules requires
stronger stimulation compared to the other granule subtypes, our results showed that these
granules continued being mobilized by Aa increasingly up to 24hrs (Figure 4.8.D). These
results demonstrate that Aa challenge induced exocytosis of all four neutrophil granule
subtypes.
To further characterize if epinephrine release by neutrophils was caused by Aa
inducing granule exocytosis, we took advantage of two degranulation inhibitors, TATSNAP23, which selectively inhibits secretory vesicles, gelatinase granules, and specific
granules (199), and TAT-Syntaxin 4 which blocks exocytosis of all four granule subtypes
(227). Human neutrophils were pre-treated with TAT-Syntaxin 4, TAT-SNAP23 or TATcontrol peptide fusion proteins, followed by Aa challenge at 15 mins, 2h, 4h and 8h.
Granule exocytosis was measured by increased plasma membrane expression of CD35
(secretory vesicles), CD66b (specific granules) and CD63 (azurophilic granules) markers
by flow cytometry and the extracellular release of MMP-9 by ELISA. Treatment with
TAT-Syntaxin 4 reduced Aa-induced mobilization of secretory vesicles (Figure 4.9.A),
gelatinase granules (Figure 4.9.B), specific granules (Figure 4.9.C), and azurophilic
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granules (Figure 4.9.D). The Aa-induced mobilization of secretory vesicles, gelatinase, and
specific granules (Figure 4.9.A-C) was significantly reduced by TAT-SNAP23 pretreatment. As expected, TAT-SNAP23 failed to inhibit Aa-induced azurophilic granules
exocytosis (Figure 4.9.D). Further, cell-supernatants were collected at each time point, and
granule content release of albumin, lactoferrin and myeloperoxidase were measured by
ELISA. Like the results obtained by flow cytometry, challenge of neutrophils with Aa for
15 min induced significant release of albumin, which was significantly reduced by pretreatment with TAT-SNAP23 and TAT-Syntaxin 4, but not TAT-control (Figure 4.10.A).
Similarly, Aa challenge for 4h induced release of lactoferrin and its release was
successfully reduced by TAT-SNAP23 and TAT-Syntaxin 4, but not TAT-control (Figure
4.10.B). As expected, neutrophils challenged with Aa for 8h resulted in significant release
of myeloperoxidase which it was inhibited by TAT-Syntaxin 4 but not TAT-SNAP23 or
TAT-control (Figure 4.10.C).
To further characterize which granule subtype store epinephrine, supernatants were
collected to measure epinephrine levels by ELISA. Aa challenge of human neutrophils at
15 mins showed no significant release of epinephrine similar to basal and TAT-control
(Figure 4.11.A). Moreover, Aa challenge at 2h induced significant release of epinephrine
in human neutrophils, pre-treatment of TAT-Syntaxin 4 was able to inhibit epinephrine
release but TAT-SNAP23 failed to inhibit release (Figure 4.11.B). On the other hand, only
pre-treatment with TAT-Syntaxin 4, but not TAT-SNAP23, blocked Aa-induced
epinephrine released after 4h (Figure 4.11.C) and 8h (Figure 4.11.D) of bacterial challenge.
Since TAT-SNAP23 does not inhibit azurophilic granule exocytosis, these results
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demonstrate that epinephrine is stored in azurophilic granules. Further, this shows that
epinephrine release by neutrophils is linked to granule exocytosis.
A. actinomycetemcomitans interacts with epinephrine in a QseC dependent manner
To determine if Aa interacts with epinephrine, increasing CFUs of Aa were incubated
with a fixed concentration of recombinant epinephrine. Epinephrine interaction with Aa
increased with increasing Aa CFUs (Figure 4.12.A). Previous work in our lab demonstrated
that QseBC was required for Aa biofilm growth and virulence (88) and that, the periplasmic
domain of QseC was required for activation of the TCS by catecholamines and iron (91).
Therefore, we performed epinephrine dose interaction assays using various Aa strains
deficient for QseC. Interaction of epinephrine was diminished by deletion of the QseC
sensor (DqseC) and in the strain expressing QseC with an in-frame deletion of the
periplasmic domain (qseCDp) (Figure 4.12.B). The ability of epinephrine to interact with
Aa was restored when the qseC gene was complemented into the QseC deletion mutant
(DqseC-comp) (Figure 4.12.B). These results show that Aa interaction with epinephrine
requires QseC and is dependent on the QseC periplasmic domain.
Epinephrine from human neutrophils promotes A. actinomycetemcomitans growth and
qseBC expression.
To determine if the epinephrine levels released by human neutrophils could promote
bacterial growth, the supernatants and cell lysates were collected from cells stimulated with
latrunculin A and fMLF and used to assess Aa growth and expression of the qseBC operon.
Aa was grown anaerobically in CDM alone or supplemented individually or in combination
with neutrophils supernatant, neutrophil cell lysate, iron (100μM) or epinephrine (50μM).
Growth in CDM supplemented with neutrophil lysate or epinephrine alone was comparable
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to the unsupplemented CDM control (Figure 4.13.A). Supplementation with iron, either
alone or in combination with epinephrine resulted in a significant induction of Aa growth
(Figure 4.13.A). Further, medium supplemented with neutrophil supernatant alone
promoted growth, which was increased when supplemented with iron (Figure 4.13.A). On
the other hand, neutrophil cell lysate supplemented with iron promoted growth similar to
epinephrine + iron or neutrophil supernatant alone (Figure 4.13.A). Supplementation with
epinephrine, neutrophil supernatant or lysate alone failed to induce expression of QseBC
(Figure 4.13.B). QseBC expression was significantly induced by iron and a further
significant increase in expression occurred by supplementation with a combination of iron
with

epinephrine

or

neutrophil

supernatant

(Figure

4.13.B).

Unexpectedly,

supplementation with iron and neutrophil lysate suppressed QseBC expression (Figure
4.13.B). This experiment was performed under aerobic conditions with similar results (data
not shown). Here, we show that Aa makes use of neutrophil-derived epinephrine to promote
bacterial growth and expression of the QseBC in the anaerobic environment.
Discussion
The newly emerging field of microbial endocrinology (168, 170) studies the
communication

or

inter-kingdom

signaling

(155)

that

has

evolved

between

microorganisms and their hosts. The study of inter-kingdom signaling includes the study
of hormonal communication, where microorganisms respond to the host neurohormones
as environmental cues to regulate the expression of genes necessary for virulence and
survival (167, 169, 171-173).There are reports of host-pathogen crosstalk involving Aa
biofilm sequestering and taking up IL-1β (228). Additionally, it has been shown previously
that Aa expresses a cytokine binding receptor, BilRI, that allows it to benefit from cytokine
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release to promote biofilm formation and bacterial growth (229, 230). Previous work by
our group demonstrated that the presence of catecholamines and iron in vitro promoted Aa
growth and regulated the expression of genes necessary for virulence and survival in the
anaerobic environment (91). However, those studies did not determine if similar effects
occurred in vivo. Based on work by others it is known that there is a large infiltration of
neutrophils at the subgingival pocket during periodontitis (27, 35, 231) and murine
neutrophils have been shown to release and synthesize catecholamines when stimulated
with LPS (166). Therefore, we considered human neutrophils as a potential source of
catecholamines for Aa. In our ex-vivo studies, we showed that Aa induces epinephrine
release in human neutrophils depleting stored catecholamine levels (Figure 4.14.A) and
indirectly inducing catecholamine synthesis (Figure 4.14.E). As a novel finding we
identified azurophilic granules as the storage location of epinephrine in human neutrophils
and that Aa gains access to epinephrine by inducing granule exocytosis (Figure 4.14.B).
Then, showed that QseC is required for epinephrine interaction with Aa (Figure 4.14.C).
Finally, we proved that host-derived epinephrine promoted Aa growth and QseBC
expression under anaerobic conditions (Figure 4.14.D).
Marino et al (224) detected catecholamines in human peripheral blood
mononuclear cells medium but the report failed to determine if these catecholamines were
released and if so, what stimuli induced release. Likewise, catecholamine release has been
shown in other immune cells such as rat and human lymphocytes (232, 233). Although,
there is extensive work done in murine neutrophils there was no report of human
neutrophils releasing catecholamines and an identified stimulus. Here, we present for the
first time that human neutrophils release epinephrine when stimulated with latrunculin A
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+ fMLF and when challenged with Aa, but not by F. alocis which occupies the same oral
niche as Aa. These observations support previous findings by Parantainen et al (203), the
first to identify endogenous catecholamines in human neutrophils. However, at the time
the source of these catecholamines was not determined or if neutrophils participated in
catecholamine synthesis. Later, further evidence of catecholamines present intracellularly
in human neutrophils was found and enzymes involved in catecholamine metabolism were
detected by high performance liquid chromatography (HPLC) (234). In our experiments,
we observed the levels of epinephrine in cell lysates increased after 8h and 24h of bacterial
challenge suggesting de novo catecholamine synthesis by human neutrophils. This was
confirmed by the presence of significant levels of tyrosine hydroxylase levels in the
presence of Aa. In contrast, dopamine β-hydroxylase levels decreased when Aa was
present. Tyrosine hydroxylase catalyzes the first and rate limiting step of the catecholamine
synthesis pathway, explaining larger amounts of this enzyme. A potential reason for this is
that dopamine β-hydroxylase catalyzes dopamine into norepinephrine, and not all
dopamine will be catalyzed explaining the decrease in enzyme levels. We also found
significant levels at 4h of the catecholamine inactivating enzymes catechol-omethyltransferase and monoamine oxidase-A. This correlates with the increased
epinephrine release induced by Aa at 4h, as epinephrine is released demand for degradation
increases. Similarly, as stored epinephrine is depleted there is demand for catecholamine
synthesis at later time points, and inactivation enzymes decrease at this time. A potential
limitation of our study is that granule exocytosis experiments were done under aerobic
conditions and not under low oxygen or anaerobic conditions. The periodontal pocket is
considered a hypoxic environment, with decreasing oxygen levels as the depth of the
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periodontal pocket increases, becoming increasingly hypoxic during infection due to
activation of the NADPH oxidase complex (235, 236). Therefore, it is likely that
neutrophils are exposed to hypoxic conditions in vivo when recruited to the gingival pocket.
Although, we did not performed experiments with both Aa and neutrophils under anaerobic
conditions, preliminary work in our lab with neutrophils challenged with Fa showed no
difference in the lifespan of neutrophils grown aerobically or anaerobically. Additionally,
untreated neutrophils under anerobic conditions resulted in enhanced viability compared
to cells grown aerobically. Though, we infer that human neutrophils will undergo granule
exocytosis under hypoxic condition, this remains to be tested in the future.
We demonstrated that Aa induces the mobilization of secretory vesicles, gelatinase
granules, specific granules and azurophilic granules in human neutrophils. These findings
align with previous observations that identified enhanced surface expression of CD63 and
CD66b in oral neutrophils, characteristic of neutrophils that are undergoing active granule
exocytosis (237, 238). Johansson et al (110) showed that purified leukotoxin A induces
release of granule contents from human neutrophils, and the authors observed increased
expression of CD63 and CD66b along with the release of elastase and lactoferrin. In our
ex-vivo model we obtained similar observations by challenging human neutrophils with a
low leukotoxic strain of Aa compared to high concentrations of purified leukotoxin.
Further, through selective inhibition of granule exocytosis, we identified azurophilic
granules as the storage location for epinephrine in human neutrophils. To the best of our
knowledge this observation serves as the first evidence of the storage location of
epinephrine in human neutrophils. Human neutrophils are recruited out of circulation by
interaction with neutrophil-specific adhesion molecules on the blood vessel wall. This
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interaction in addition to chemoattractants gradient such as IL-8 promotes the mobilization
of secretory vesicles. Once neutrophils cross through the epithelium, they continue to
receive signals such as increasing IL-8 gradient potentially released by gingiva epithelial
cells and formyl peptides from invading bacteria, resulting in mobilization of gelatinase
granules. The primed neutrophil arrives at the infected subgingival pocket where there are
overwhelming inflammatory signals that may induce the release of specific and azurophilic
granules. Alternatively, these granules can fuse with vacuoles containing phagocytized
bacteria, forming a phagosome (49-51). Thus, Aa may induce the release of azurophilic
granules at the subgingival pocket to gain access to epinephrine and in turn the release of
potent antimicrobial protein contents of these granules may contribute to tissue damage
and disease progression.
When human neutrophils were challenged with Aa for 2h we expected to see a high
release of epinephrine, due to depleted epinephrine levels in cell lysate. A plausible
explanation to the difference in levels of epinephrine released versus stored at 2h is that
some of the epinephrine released could be interacting with Aa therefore no longer in the
supernatant. Epinephrine interaction with Aa increased with increasing Aa CFUs. Further,
Aa interaction with epinephrine was found to require QseC, in a QseC periplasmic domain
dependent manner. This supports previous findings made by our group that identified
catecholamines (norepinephrine and epinephrine) as the signal that is sensed by QseC and
that the periplasmic domain of QseC is required for qseBC operon expression in the
presence of catecholamines and iron (91). It also strengthens the importance of QseC in
recognizing catecholamines for growth and virulence of Aa (88). The exact details of the
interaction of Aa with epinephrine remains unclear, but the discussed results make us
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conclude that the QseC periplasmic domain is required. As for a receptor for epinephrine,
when Aa is grown in the presence of catecholamines and iron the expression of the
enterobactin operon, which contains a gene for FepA, remains unchanged (91). In E. coli,
FepA is an outer membrane protein that serves as a receptor for the ferric enterobactin
siderophore (239, 240). The uptake of this siderophore into the bacterial cells is TonBdependent (240, 241). We performed different experiments to determine if FepA was
required for Aa interaction with epinephrine using a ΔfepA mutant Aa strain, but results
were inconclusive (data not shown). Moreover, as an alternative for iron entry into the
bacterial cells there is the ferrous iron transport system (Feo) and periplasmic-binding
protein-dependent transport (PBT) (143-146). These are predominant iron transport
systems at low oxygen conditions when ferrous iron is stable and is more prevalent than
ferric iron (147). In the case the ferric iron is predominant it will be chelated by ferric iron
reductases and then uptake is mediated by ferrous permeases (148, 149). Rhodes et al (132)
demonstrated that Aa makes use of inorganic iron to grow under chelated conditions and
proposed that Aa may acquire iron through the expression of systems which function
independently of an outer membrane receptor or TonB dependent transport. The
elucidation of which TonB and receptor independent iron transport system is used by Aa
will require further investigation.
Under anaerobic conditions we showed that Aa growth in limited media is
promoted in the presence of neutrophils supernatant or cell lysate supplemented with iron.
Likewise, supplementation with neutrophil supernatant and iron induced expression of
QseBC. Interestingly, neutrophil cell lysate alone or supplemented with iron QseBC
expression was suppressed. Human neutrophils lysates contain all internal contents of
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neutrophils, including components such as calprotectin. Calprotectin is a metal binding
protein, abundant in neutrophils cytoplasm (242, 243). Another protein that is found in
specific granules is the neutrophil gelatinase-associated lipocalin. This protein scavenges
iron from siderophores, and it has been shown to remove iron from catecholamines as well
(244). These proteins can be sequestering the supplemented iron competing with
epinephrine present in lysate, making it unavailable to Aa and consequentially suppressing
the induction of the QseBC.
In Aa positive subjects, F.alocis was detected at high levels (225) and F. alocis
accumulation in the oral biofilm has been shown to be stimulated by the presence of
specific strains of Aa (226). Based on our experiments we determined that F. alocis does
not induce release of epinephrine in human neutrophils. This result goes in hand with
previous findings that F. alocis does not induce the exocytosis of azurophilic granules (245,
246). In the case that F. alocis is found to be catecholamine-responsive it will suggest that
it may be benefiting from ability of Aa to induce epinephrine release. However, at the
present there is no report of F. alocis being influenced in some way by catecholamines. Aa
has also been found associated to Fusobacterium nucleatum, which growth is increased by
hormones like epinephrine and norepinephrine (174), Lactobacillus spp. expresses
transporter systems for uptake of catecholamines (247) and other catecholamineresponsive species such as Prevotella spp and Leptotrichia (168, 248, 249). Some of these
bacteria have been shown to lack the ability to produce siderophores as is the case of Aa
(250, 251). Therefore, it is likely that these bacteria work as team to thrive in the
subgingival pocket, where Aa role may be to induce catecholamine (i.e., epinephrine)
release by the infiltrating human neutrophils.
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In conclusion, our ex-vivo experiments demonstrated that human neutrophils store
and release epinephrine upon stimulation with latrunculin A + fMLF. We show that Aa can
induce epinephrine release in human neutrophils, consequently depleting epinephrine
storage and promoting catecholamine metabolism. Further, one of the most important
contributions of this study was the finding of azurophilic granules as the storage location
of epinephrine in human neutrophils and that Aa gains access to it by inducing granule
exocytosis. Additionally, we found that epinephrine interaction with Aa depends on QseC
expression and requires the QseC periplasmic domain. Finally, human-neutrophil derived
epinephrine supplemented with iron promoted Aa growth and QseBC expression under
anaerobic conditions. The presented findings supply evidence towards the growing field of
microbial endocrinology by contributing to the understanding of the crosstalk between
bacteria and the host endocrine system. Further it expands the knowledge of the role of
stress hormones in periodontal disease and potentially other chronic inflammatory
diseases.
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Figure 4.1. Murine neutrophils release epinephrine upon LPS challenge but human
neutrophils do not. Murine neutrophils (1 × 106 cells/ml) were left untreated (UT) treated

with LPS for 5 mins and 4h to replicate previous findings and induce epinephrine release
(A). Human neutrophils (4 × 106 cells/ml) were challenged with LPS for 1h, 2h, 4h, 8h and

24h (B-C). Epinephrine content was measured by ELISA from collected supernatant LPS
challenged murine neutrophils (A) and supernatant and cell lysate of neutrophils treated
with LPS (B-C). Epinephrine content was determined by ELISA. Epinephrine concentration
is plotted as the mean ± SD of a N = 3 (A) or N = 5 (B-C). Statistical differences among
experimental conditions and time points were analyzed by one-way ANOVA followed by
Tukey’s post-test. ns = not significant, *p < 0.05.
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Figure 4.2. Human neutrophils release epinephrine upon A. actinomycetemcomitans
challenge. Human neutrophils (5 × 106 cells/ml) were treated with fMLF, Latrunculin A

(LAT) + fMLF, LPS or IL-8 to induce epinephrine release. Epinephrine content was
determined in neutrophils supernatant (A) and cell lysate (B) by ELISA. Human neutrophils
(3 × 106 cells/ml) were challenged with Aa (MOI 50) for 2h, 4h, 8h and 24h. At the end of
each time point supernatant (C) and cell lysates (D) were collected and epinephrine
content was measured by ELISA. Epinephrine concentration is plotted as the mean ± SD of
4 independent experiments. Peaked epinephrine release/content bars are in blue.
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Statistical differences among experimental conditions and time points were analyzed by
one-way ANOVA (A, B) or repeated measures one-way ANOVA (C, D), followed by Tukey’s
post-test. ns: not significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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Figure 4.3. A. actinomycetemcomitans induces epinephrine release in highly purified
human neutrophils. Isolated human neutrophils were highly purified (see Methods)

starting from a >90-95% pure neutrophil isolation, confirmed by flow cytometry staining
using the gating strategy shown in panel A (A). and then challenged with Aa (MOI 50) for
2h, 4h, 8h and 24h and epinephrine content was measured by ELISA from collected
supernatant (B) and cell lysate (C). Epinephrine concentration is plotted as the mean ± SD
of 3 independent experiments. Peaked epinephrine release/content bars are in blue.
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Statistical differences among experimental conditions and time points were analyzed by
repeated measures one-way ANOVA, followed by Tukey’s post-test. ns: not significant, *p
< 0.05, **p < 0.01.
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Figure

4.4.

Human

neutrophils

are

viable

after

24h

exposure

to

A.

actinomycetemcomitans. Neutrophil viability when challenged with Aa was determined by

cytospin imaging (A-B) and Trypan Blue exclusion (C). Human neutrophils were challenged
with Aa (MOI 50) for 0h, 4h, 8h, 24h, centrifuged and washed with RPMI-1640. Neutrophils
were suspended at 1 x 105 cells in RPMI-1640 and human serum. The cell suspension was
loaded into the funnel chamber and assembled on the cytocentrifuge clip, with slide and
filter. Cytocentrifuge clip was centrifuged, and the microscope slide was removed from
cytocentrifuge clip and fixed and stained. Images of unchallenged neutrophils (A) and Aa
challenged neutrophils (B) are shown. Neutrophils were diluted 1:20 in Trypan blue at 0h,
4h, 8h, 24h and live cells were counted using a hemacytometer (C). Viability counts are
plotted as the mean ± SD of 3 independent experiments. Statistical differences among time
points were analyzed by two-way ANOVA, followed by Bonferroni’s post-test. ns: not
significant, *p < 0.05
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Figure 4.5. A. actinomycetemcomitans promotes increased levels of enzymes involved in
catecholamine metabolism in human neutrophils. Human neutrophils were challenged

with Aa (MOI 50) for 2h, 4h, 8h and 24h; cell lysates were collected and the levels of
tyrosine hydroxylase (A), dopamine β-hydroxylase (B), catechol-O-methyltransferase (C)
and monoamine oxidase A (D) were measured by ELISA. Enzymes levels are plotted as the
mean ± SD of 3 independent experiments. Statistical differences among experimental
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conditions and time points were analyzed by repeated measures one-way ANOVA,
followed by Tukey’s post-test. ns: not significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p
< 0.0001.
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Figure 4.6. F. alocis is unable to induce epinephrine release in human neutrophils. Human

neutrophils were challenged with F. alocis (MOI 10) for 1h, 2h and 4h. Epinephrine content
was measured by ELISA from collected supernatant (A) and cell lysate (B) of F. alocis
challenged neutrophils. Epinephrine concentration is plotted as the mean ± SD of 5
independent experiments. Statistical differences among experimental conditions and time
points were analyzed by repeated measures one-way ANOVA, followed by Tukey’s posttest. *p < 0.05, **p < 0.01, ***p < 0.001.
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Figure 4.7. Gating strategy and histograms used in flow cytometric analysis of granule
exocytosis by human neutrophils. Flow cytometry staining was performed using the shown

gating strategy and examples of histogram peak shift for each granules marker CD35 (A),
CD66b (B) and CD63 (C).
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Figure 4.8. A. actinomycetemcomitans induces exocytosis of all four neutrophil granule
subtypes. Induction of neutrophil granule exocytosis was determined by challenging

human neutrophils with Aa (MOI 50) for 1.5h, 6h, 8h and 24h. Increase plasma membrane
expression of CD35 (A), CD66b (C), and CD63 (D) was measured to define secretory
vesicles, specific granules, and azurophil granule exocytosis, respectively, by flow
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cytometry. Basal levels and latrunculin (Lat) + fMLF were used as negative and positive
control. Granule markers are plotted as the mean channel florescence intensity (MFI) ±
SEM of 3 independent experiments. For gelatinase granules exocytosis, cell supernatants
were collected at basal and following each stimulation, and levels of matrix
metallopeptidase 9 (MMP-9) were measured by ELISA (B). MMP-9 concentration is plotted
as the mean ± SD of 3 independent experiments. Bars in blue are the selected time points
used in the selective inhibition granule release experiments (Figure 4.9). Statistical
differences among experimental conditions and time points were analyzed by repeated
measures one-way ANOVA, followed by Tukey’s post-test. ns: not significant, *p < 0.05,
**p < 0.01, ***p < 0.001, ****p < 0.0001.
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Figure 4.9. Pre-treatment with TAT fusion proteins prevented A. actinomycetemcomitansinduced neutrophil granule exocytosis. Human neutrophils were unstimulated, challenged
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with Aa at MOI 50, or pre-treated with TAT-Syntaxin 4 (Syn4), TAT-SNAP23 (SNAP23), TATControl peptide (Ctrl-peptide) for 15 mins followed by Aa challenge. The peak time point
of Aa-induced granule exocytosis was different for each granule subtype. Secretory
vesicles peak was at 15 min post-bacterial challenge (A), two hours for gelatinase granules
(B), four hours for specific granules (C) and eight hours for azurophilic granules (D). Granule

markers were measured by flow cytometry and plotted as the mean channel florescence
intensity (MFI) ± SEM of 4 independent experiments (A, C-D). For gelatinase granules,
matrix metallopeptidase 9 (MMP-9) was measured from human neutrophils supernatant
by ELISA and MMP-9 concentration is plotted as the mean ± SD of 4 independent
experiments (B). Bars in blue are neutrophils challenged with Aa. Statistical differences
among experimental conditions were analyzed by ordinary one-way ANOVA, followed by
Tukey’s post-test. ns: not significant, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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Figure 4.10. Granule content markers confirm inhibition of granule exocytosis induced by
A. actinomycetemcomitans in human neutrophils. Granule fusion inhibition with TAT

peptides was confirmed by measuring granule contents. Human neutrophils were pretreated with Syntaxin 4 (Syn4) or SNAP23 peptide for 15 mins, then challenged with Aa
(MOI 50) for 15 mins for secretory vesicles (A), for 4h for specific granules (B) and for 8h
for azurophilic granules (C). Albumin (A), lactoferrin (B) and myeloperoxidase (C) were
measured from collected supernatants and detected by ELISA. The concentration of each
content marker is plotted as the mean ± SD of 4 independent experiments. Bars in blue are
neutrophils challenged with Aa. Statistical differences among experimental conditions
were analyzed by ordinary one-way ANOVA, followed by Tukey’s post-test. ns: not
significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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Figure 4.11. Epinephrine release of TAT peptide treated samples shows that human
neutrophils store epinephrine in azurophilic granules. Epinephrine storage location was

determined by pre-treating human neutrophils with Syntaxin 4 (Syn4) or SNAP23 peptide
for 15 mins, then challenged with Aa (MOI 50) for 15 mins (A), 2h (B), 4h (C) and 8h (D).
Epinephrine concentrations are plotted as the mean ± SD of 3 independent experiments.
Bars in blue are neutrophils challenged with Aa. Statistical differences among experimental
conditions and time points were analyzed by ordinary one-way ANOVA, followed by
Tukey’s post-test. ns: not significant, *p < 0.05, **p < 0.01, ***p < 0.001, ****p < 0.0001.
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Figure 4.12. A. actinomycetemcomitans interacts with epinephrine in a QseC dependent
manner. The interaction of epinephrine and Aa was determined by incubation of increasing

colony forming units (CFUs) of Aa with 250 pg/ml of recombinant epinephrine. Associated
epinephrine was plotted against increasing CFUs of Aa (A). Requirement of QseC for
epinephrine interaction with Aa was determined by incubation of the bacterium with
increasing concentrations of recombinant epinephrine (0-500 pg/ml) (B). Epinephrine
levels were measured by ELISA and plotted as the mean ± SD of 5 independent
experiments. Statistical differences among experimental conditions were analyzed by
ordinary one-way ANOVA (A) or two-way ANOVA (B), followed by Tukey’s post-test. *p <
0.05, **p < 0.01.
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Figure 4.13. Host-derived epinephrine promotes A. actinomycetemcomitans growth and
qseBC expression. The supernatants and lysates from human neutrophils stimulated with

latrunculin A and fMLF were collected and used as supplement for chemically defined
media (CDM). Aa was grown under anaerobic conditions in CDM alone or supplemented
with human neutrophils supernatant (104), cell lysate (Lysate), iron (FeCl2, 100μM) or
Epinephrine (Epi, 50μM). At designated times growth was measured by determining the
OD600 (A). Aa strain (that harbors the qseBC promoter-lacZ reporter plasmid pDJR29) was
grown under anaerobic conditions in CDM alone or supplemented with human neutrophils
supernatant (104), cell lysate (Lysate), iron (FeCl2, 100μM) or Epinephrine (Epi, 50μM).
Expression of the qseBC operon was determine by measuring β -galactosidase activity after
24h (B). The OD600 measurements for growth were plotted as the mean ± SEM of 3
independent experiments (A). The expression of the qseBC operon is presented in miller
units as the mean ± SD of 3 independent experiments (B). Statistical differences among
experimental conditions were analyzed by two-way ANOVA (A) or ordinary one-way
ANOVA (B), followed by Tukey’s post-test. ns: not significant, **p < 0.01, ***p < 0.001,
****p < 0.0001.
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CHAPTER 5
LA TÓXICA: THE EFFECT OF AGGREGATIBACTER
ACTINOMYCETEMCOMITANS LTXA IN HUMAN NEUTROPHILS EFFECTOR
FUNCTIONS

Introduction
Periodontal disease is defined as an inflammation of the gingiva caused by
accumulation of oral microorganisms. The depth of the gingival pocket increases due to
continuous periodontal ligament and alveolar bone destruction (4). Aa is a Gram-negative
opportunistic oral pathogen, facultative anaerobe and non-motile coccobacillus of the
Pasteurellaceae family, associated with localized periodontitis (88, 90, 91). Aa contributes
to tissue inflammation, destruction, and bone resorption by expressing a number of
virulence factors such as leukotoxin A (LtxA) (109, 182, 252).
In periodontitis, neutrophils are the first to arrive in large numbers to the infected
gingival pocket (35). Primed neutrophils arrive and create a defensive wall against the
biofilm associated with the tooth to prevent bacteria from moving deeper into tissue (48).
At the infected subgingival pocket (Figure 5.1), the neutrophils are exposed to an
overwhelming number of inflammatory signals that induce different effector functions
such as the phagocytosis of invading bacteria. Neutrophil phagosomes containing
internalized bacteria can fuse with azurophilic granules to form a phagosome where
engulfed microbes are exposed to antimicrobial peptides, enzymes and reactive oxygen
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species (ROS) (49-51). The canonical fate of this process is complete clearance of the
bacteria. However, studies on the interaction of Aa and neutrophils have shown
inconsistent results regarding phagocytosis and killing of Aa by neutrophils (129). Aa
expresses the leukotoxin LtxA, a pore forming toxin that targets leukocytes and
permeabilizes the cell membrane for efflux of cytosolic potassium ions and influx of
calcium (253). Although Aa induces the formation of ROS (254), some reports suggest that
the resistance to neutrophils activity depends on Aa expression of LtxA and that hyper
leukotoxic strains such as JP2 are highly resistant (255-259). Others studies suggest that
Aa resists neutrophil killing regardless of leukotoxin phenotype (129, 260). Aa can induce
granule exocytosis, releasing MMP8, epinephrine, and through LtxA, induce the release of
elastase and lactoferrin (183, 210) contributing to epithelial barrier tissue damage and
bacteria migration deeper into the subgingival pocket. Another effector function of
neutrophils induced by Aa is the formation of neutrophils extracellular traps (NETs), which
occurs after ROS production and is accompanied by degranulation (52, 261).
Until recently Aa was suggested to accelerate apoptosis (129) or induce necrosis
through LtxA cell lysis (183) in human neutrophils, yet its sublytic effect is not well
understood. Pore forming toxins have been associated with cytoplasmic vacuolation, which
in turn is associated with non-canonical cell death types. Cytoplasmic vacuolation or
vacuolization occurs when a cell is exposed to environmental stress (57-59). This
environmental stress can be produced by “inducers” such as pore forming toxins (i.e.,
LtxA), acting as ion channels. The concentration and time of exposure to an inducer
determines if a cell will commit to a cell death pathway (58, 60-62).
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Sialic acid-binding Ig-type lectin 9 (Siglec-9) is associated with cytoplasmic
vacuolization in neutrophils (64). Siglecs are expressed in the membrane of most white
blood cells and recognize sialic acid-containing glycans. They serve as an immunesurveillance system to distinguish host cells from foreign cells, and regulate unwanted
immune responses (66-70). To no surprise, pathogens have evolved mechanisms to
disguise themselves by incorporating sialic acid-containing glycans on the cell surface to
suppress the immune response (70). Different members of the Pasteurellaceae family, such
as Haemophilus influenzae, Actinobacillus actinomycetemcomitans (currently known as
Aggregatibacter actinomycetemcomitans) and Pasteurella haemolytica have been shown
to express specialized proteases and transferases for sialic acid and to possess sialic acid
on their LPS structures (74, 75). Bacteria with this characteristic are known as sialylated
bacteria and Siglec-9 has been shown to negatively regulate the innate immune response
against these organisms (71). Zeng et al. (83) demonstrated that Siglec-E (the Siglec-9
mouse homolog) is involved in modulating neutrophil functions, including induction of
apoptosis, inhibition of cellular activation, suppression of migration, modulation of
oxidative stress, and regulation of inflammatory cytokines secretion. More recently, Wu et
al. (84) revealed that Gram-negative bacteria enhance Siglec-E activation in murine
neutrophils and dampen the innate response toward Gram-negative bacteria. The role of
Siglec-9 in periodontitis has been highlighted in a review by Sudhakara et al. (85) where it
mentions that sialic acid adorned P. gingivalis interacts with Siglec-9 attenuating
neutrophils inflammatory signaling. However, the role of Siglec-9 in Aa and its ability to
induce non-apoptotic cell death in neutrophils remains unknown. In this chapter, within
our study model, we characterize the effect of Aa and sublytic kevels of LtxA in human
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neutrophils. We also determine the ability of Aa to induce cytoplasmic vacuoles and alter
Siglec-9 expression in neutrophils. The findings presented here provide a foundation to
support further study of the role that Siglec-9 plays in periodontitis and as a novel
mechanism exploited by Aa to dampen the inflammatory response. Finally, our results
contribute to current knowledge of other roles played by LtxA at sublytic levels during
periodontal disease.
Results
Human neutrophils membrane integrity is compromised by A. actinomycetemcomitans
challenged with minimal cytotoxicity
Given that Aa expresses the pore-forming toxin LtxA, that is known to target the
neutrophil membrane, leading to cell lysis, we first sought to determine a multiplicity of
infection (MOI) to use in experiments that will not result in neutrophil cell death. Human
neutrophils (3x106 cells/ml) were exposed to increasing MOIs of Aa (5-50) for 0, 15, 30,
60, 120 and 240 mins shaking in water bath at 37°C. The cytotoxic effect of Aa on
neutrophils was determined by measuring released lactate dehydrogenase (LDH) using a
colorimetric assay. As expected, some toxicity was induced by Aa, and it increased with
time but remained under 40% (Figure 5.2.A). Additionally, there was no significant
difference in cytotoxicity within each time point, regardless of bacteria MOI.
Consequently, MOI 50 was selected to be used in our experiments.
Next, we determined if neutrophil membrane integrity was affected by Aa. Human
neutrophils (3x106 cells/ml) were challenged with Aa or heat killed (HK) Aa at a MOI of
50 in suspension for 15, 30 and 60 mins shaking in water bath at 37°C. Samples for each
time point were mounted onto a coverslip and fixed with 4% paraformaldehyde (PFA). The
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neutrophil membrane was labeled with wheat germ agglutinin (WGA) lectin which binds
N-acetyl-D-glucosamine and sialic acid and Aa was labeled with CFSE before infection.
Confocal microscopy (Figure 5.2.B-C) was used to evaluate the internalization of WGA in
neutrophils challenged with Aa. As a positive control, neutrophils were treated with 0.1%
Triton X to permeabilize cells and allow WGA to enter the cells (Figure 5.2.B). Confocal
imaging showed no WGA inside the untreated neutrophils, However, when neutrophils
were challenged with Aa, WGA accumulation was observed starting at 30 mins. On the
other hand, HK Aa had no WGA accumulation but it did show an increased number of
bacteria inside the cell (Figure 5.2.C). To quantify membrane integrity of neutrophils when
challenged with Aa we used a vital impermeable nuclear dye, TO-PRO-3 and flow
cytometry imaging. Neutrophils (4x106 cells/ml) were challenged with Aa (MOI 50) for 5,
15, 30, 60 and 90 mins in suspension, shaking in a water bath at 37°C. Neutrophils were
stained with TO-PRO-3 and visualized by imaging flow cytometry. As positive controls,
neutrophils were treated with 0.1% Triton X and neutrophils with red nuclei were
considered positive and those with absence of red were considered negative (Figure 5.3.B,
top). TO-PRO-3-stained nuclei of Aa challenged neutrophils were observed at all time
points (Figure 5.3.A). In Figure 5.3.B (bottom) we show the quantification of TO-PRO-3
negative vs positive neutrophils. Untreated neutrophils did show TO-PRO-3 nuclei staining
but the positivity was of 24.5% at 90 mins. In comparison, after 5 mins of bacterial
challenge 56.5% of neutrophils had TO-PRO-3 labeled nuclei. Compared to TO-PRO-3
negative neutrophils, the positivity significantly increased to 88% by 15 mins (p = 0.0021),
89.5% at 30 mins (p-value = 0.0386), 90.5% at 60 mins (p-value = 0.0005) and to 93.5%
by 90 mins (p-value = 0.0474).
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A. actinomycetemcomitans at lower MOIs can be phagocytized by human neutrophils
Since our results showed decreased membrane integrity and cytotoxicity, but trypan
blue staining showed that neutrophils lifespan is extended to at least 24h (Chapter 4, Figure
4.4.C) we wanted to determine if neutrophils were functionally active. To test neutrophil
functionality, we determined the ability of human neutrophils to internalize Aa. Fresh
human neutrophils (4x106 cells/ml) were challenged with Aa (MOI 10) and at 5, 30 and 60
min, infected cells were mounted and fixed onto coverslips. Intracellular and extracellular
bacteria were differentially stained as described in the Materials and Methods. Briefly,
extracellular Aa, was labeled with mouse polyclonal anti-Aa (1µg/ml) primary antibody
and a goat anti-mouse Alexa Fluor 488. Antibody linkages were fixed by with 4% PFA for
10 min. To stain internalized Aa, neutrophils were permeabilized with 0.02% saponin and
labeled with mouse anti-Aa primary antibody in 3% BSA-PBS with 0.02% saponin and
incubated and washed as before. Finally, goat anti-mouse Alexa Fluor 647 in 3% BSAPBS with 0.02% saponin was used as a secondary antibody. This results in differential
staining of internal vs external bacteria, where bacteria in red have been internalized,
whereas yellow corresponds to extracellular bacteria (Figure 5.4.A). Plates were incubated
at room temperature as previously described and washed twice with 1X PBS. Phagocytosis
of neutrophils challenged with Filifactor alocis (Fa), an assay that is well established in
our lab, was used as a phagocytosis assay control. By 15 mins, 35% of neutrophils had
internalized Fa (Figure 5.4.B) and by 60 mins 44% neutrophils internalized Fa with no
significant difference throughout the length of the experiment, confirming the capacity of
internalization of Fa by human neutrophils as previous demonstrated (246). In contrast, by
15 mins only 17.33% of neutrophils challenged with Aa had internalized bacteria (Figure
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5.4.C), by 30 mins the percentage of neutrophils increased significantly to 20% (p-value =
0.0277) and 31% by 60 mins (p-value = 0.0202) when compared to 15 mins. Additionally,
we observed that the number of neutrophils that internalized bacteria increased with time
as shown by the percentage of neutrophils that internalized Aa from 30 mins to 60 mins (pvalue of 0.0197). In summary, we demonstrated that neutrophils were functionally active,
that Aa can be internalized at low MOIs (MOI 10) and that the number of neutrophils that
internalize Aa increased with time.
A. actinomycetemcomitans resists internalization by human neutrophils at higher MOIs
Aa is known to resist phagocytosis and this is considered to be dependent on LtxA
expression. However, previous work has been done using highly leukotoxic strains such as
JP2 which produces 8-10 times more LtxA than Aa 652 (112), yet the ability of minimal
leukotoxic strains to resist internalization is often overlooked. Therefore, we wanted to
determine if Aa resistance to phagocytosis is due to if LtxA expression. For this experiment
we used Aa 652 (minimally leukotoxic), JP2 (highly leukotoxic), JP2 ΔltxA (does not
express LtxA) and as a control we used heat killed (HK) Aa 652. Human neutrophils (4x106
cells/ml) were challenged with Aa 652, JP2, JP2 ΔltxA at increasing MOIs of 10, 25, 50
and 100. Cells were challenged for 30 mins in suspension, shaking in a water bath at 37°C.
Following, each condition was mounted and fixed into a coverslip and bacteria was
differentially stained as described above. In Figure 5.5.A we observed that neutrophils
challenged with Aa showed no change in morphology, and although there are bacteria
internalized, there is no visual increase in the number of internalized bacteria. Interestingly,
we observed similar results for JP2 ΔltxA challenged neutrophils. Neutrophils challenged
with JP2, were similar to those challenged with Aa 652, or JP2 ΔLtxA at MOI 10 and MOI
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25 (Figure 5.5.A), but after 30 mins of challenge, JP2 induced increased cell lysis.
Similarly, at higher MOIs of 50 and 100, JP2-treated neutrophils underwent cell lysis and
only cell debris was visualized. For this experiment we only quantified neutrophils
challenged with Aa 652, HK Aa or JP2 ΔLtxA at MOI 50. Neutrophils challenged with JP2
at this MOI had undergone cell lysis and neutrophils that had internalized, associated or no
bacteria could not be quantified. By 15 mins 8.3% of neutrophils had internalized Aa 652,
by 30 mins, 6.67% and by 60 mins 7% of neutrophils had internalized Aa 652 (Figure
5.5.B, left panel). Similar to what we observed in confocal images (Figure 5.5.A) JP2
ΔLtxA behaved comparable to Aa 652, with a percentage of 7.3% of neutrophils that
phagocytized Aa by 15 mins, increasing to 17% by 30 mins and 15.67% at 60 mins (Figure
5.5.B, right panel) suggesting that resistance to phagocytosis by human neutrophils is not
attributed LtxA or that LtxA is not the sole player in phagocytosis resistance by Aa. A
stunning 72% of neutrophils at 15 mins challenged with HK Aa 652 internalized bacteria
(Figure 5.5.B, middle panel), although not a significant increase but by 30 mins 86% and
by 60 mins 75.33% of neutrophils had internalized Aa. This suggested that phagocytosis
resistance requires viable bacteria. The number of bacteria internalized was determined and
most of the neutrophils that were challenged with Aa or JP2 ΔLtxA internalized one
bacterium (Figure 5.5.C). In contrast, neutrophils challenged with HK Aa contained 1-4
bacteria and some more than 6 bacteria. Together, we show that at high MOIs of Aa viable
bacteria can resist phagocytosis, independently of LtxA.
A. actinomycetemcomitans induces the formation of cytoplasmic vacuoles in human
neutrophils independently of LtxA expression
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Previous studies have shown that pore forming toxins can induce the formation of
cytoplasmic vacuoles. Given that Aa expresses LtxA, a pore forming toxin we sought to
determine if Aa induces cytoplasmic vacuoles in human neutrophils. Human neutrophils
(4x106 cells/ml) were challenged with Aa 652, JP2 or JP2 ΔltxA at a MOI 10 in suspension
for 0h, 0.5h, 1h and 2h at 37°C shaking in a water bath. After challenge, an aliquot of 200
μl was collected and cells were mounted by cytospin and fixed on a slide, stained with
HEMA3 to differentially stain neutrophil cells and visualized by a light microscope. LDH
release was measured from sample supernatants and detected using a colorimetric assay
and presented as percentage of cytotoxicity. We were able to identify vacuole formation in
neutrophils challenged with Aa at all time points and on most of the cells in view (Figure
5.6.A). We challenged neutrophils with JP2 and JP2 ΔltxA strains to determine if LtxA is
responsible of inducing cytoplasmic vacuoles. Cytotoxic vacuoles were observed in JP2
challenged neutrophils at all time points. However, cell numbers decreased, and round
nuclei (characteristic of apoptotic cells) were observed at later time points. Compared to
Aa 652 and JP2 ΔltxA, JP2 challenged neutrophils showed significantly higher cytotoxicity
even at a low MOI of 10 (Figure 5.6.B). As expected, challenge with the highly leukotoxic
strain JP2 for 2h at MOI 25 resulted in cell lysis (Figure 5.6.C). To our surprise, JP2 ΔltxA
induced cytoplasmic vacuoles comparable to Aa 652 (Figure 5.6.A). When neutrophils
were challenged at MOI 25 with Aa 652 or JP2 ΔltxA (Figure 5.6.A), we obtained similar
observations. These results suggest that although LtxA is a pore-forming toxin, it is not
required for the induction of cytoplasmic vacuolation.
A. actinomycetemcomitans enhances Siglec-9 expression in human neutrophils
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Cytoplasmic vacuolation in neutrophils has been associated with Siglec-9
activation (64). In addition, Wu et al. (84) demonstrated in mice that Gram-negative
bacteria enhance Siglec-E (the Siglec-9 murine homolog) expression. Considering that we
showed that Aa induces cytoplasmic vacuoles in neutrophils (Figure 5.6), is a Gramnegative bacterium, and is known to add sialic acid to its LPS (74, 75) to negatively regulate
the innate immune response, we tested the ability of neutrophils to increase Siglec-9
expression upon Aa challenge. Neutrophils (4x106 cells/ml) were challenged with Aa at
MOI 10 (the same MOI at which cytoplasmic vacuoles were induced by Aa), in suspension
for 2h at 37°C shaking in a water bath. To provide a state similar to the inflamed gingival
pocket, a separate sample of neutrophils were primed with IL-8 (10ng/ml) for 1h prior to
bacterial challenge. Briefly, cells were blocked for 15 mins, stained with human Siglec-9
PE conjugated antibody (10 µl/106 cells, Biotechne FAB1139P-100, Minneapolis, MN) for
1hr. As a control, samples were run in duplicates and stained with Mouse Ig2A PE
conjugated antibody isotype control (20 µl/106 cells, Biotechne IC003P, Minneapolis,
MN), washed twice with 0.05% sodium azide and fixed by resuspending in 1% PFA.
Siglec-9 expression was quantified by flow cytometry using a BD FACS Celesta Flow
cytometer and analyzed with FlowJo software. We observed that human neutrophils have
a baseline expression of Siglec-9 when untreated (Figure 5.7.A, right panel). Aa challenge
significantly enhanced the expression of Siglec-9 compared to UT with a p-value of 0.0049
(Figure 5.7.A). Priming of neutrophils with IL-8, a neutrophil chemoattractant, further
increased Siglec-9 expression significantly compared to Aa challenge alone (p-value =
0.0001) and IL-8 treatment alone (p-value 0.0004). It has been previously shown that in
mice, Gram-positive bacteria suppress Siglec-9 expression (84). We used two oral Gram-
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positive bacteria, Peptoanaerobacter stomatis (Ps) and Filifactor alocis (Fa) and tested if
Siglec-9 expression decreases or remains unchanged after bacterial challenge. In contrast
to the literature, we found that neutrophils treated with IL-8 followed by Ps challenge
(Figure 5.7.B, middle panel) showed significant increase in Siglec-9 expression when
compared to UT (p-value = 0.0040), similar results were obtained when unprimed
neutrophils were challenged with Ps alone (Figure 5.7.B, right panel, p-value = 0.0041).
Treatment with IL-8 followed by Fa challenge (Figure 5.7.C, middle panel) also
significantly increased Siglec-9 expression (p-value = 0.0467) as well as Fa challenge
alone (Figure 5.7.C, right panel, p-value = 0.0159). However, for both Ps and Fa priming
with IL-8 did not further enhance Siglec-9 expression.
To determine if there is a dose effect in Siglec-9 enhanced expression by Aa, we
challenged neutrophils and stained for Siglec-9 as described above and included a
challenge with Aa at MOIs 50 and 100. In these experiments, neutrophils were primed with
TNF-α (2ng/ml), a strong priming agent, for 15 min prior to bacterial challenge. Siglec-9
expression of neutrophils challenged with Aa (Figure 5.8.B) was significantly increased at
MOI 10 (p-value = 0.0048), MOI 50 (p-value < 0.0001) and MOI 100 (p-value = 0.0427)
when compared to UT. Siglec-9 expression in neutrophils peaked at MOI 50 and was
significantly higher than Siglec-9 expression with Aa 652 at MOI 10 (p-value < 0.0001) or
MOI 100 (p-value < 0.0001). Aa 652 challenge at MOI 10, significantly increased Siglec9 expression in human neutrophils compared to Ps (p-value < 0.0001) and Fa (p-value =
0.0004). Neutrophils challenged with Aa 652 at MOI 50 resulted in significant
enhancement of Siglec-9 expression in comparison to Ps (p-value < 0.0001) and Fa (pvalue < 0.0001). However, Aa 652 challenge at MOI 100 was only significantly higher
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when compared to Fa (p-value = 0.0035). In contrast to IL-8 pre-treatment, there was no
significant difference between Siglec-9 expression with Aa 652 alone and pre-treatment
with TNF-α following Aa challenge (Figure 5.8.C). In comparison to our observations in
Figures 5.7.B-C Fa and Ps did not increase Siglec-9 expression in human neutrophils. In
F. alocis this difference in results can be due to its ability to activate NF-κβ through TLR2
signaling (262). NF-κβ then activates the transcriptional factor AP-1, that binds the SiglecE (Siglec-9 homolog in mice) promoter (84). In summary, we found that human neutrophils
increase Siglec-9 expression when challenged with Aa and priming of neutrophils with IL8 further increased expression.
Discussion
Aa expresses LtxA, a pore-forming toxin that targets the leukocyte membrane. The
cytotoxic effect of LtxA has been studied extensively, such as cell lysis and release of
elastase by neutrophils (52, 183) particularly with highly leukotoxic strains. Nevertheless,
the effects of Aa at LtxA sublytic levels is frequently overlooked. In our studies we
demonstrated that neutrophils challenged with increasing MOIs (5-50) of the minimally
leukotoxic strain of Aa 652 induced some toxicity starting at 10% and it increased with
time but remained under 40%. Moreover, there was minimal variation in cytotoxicity
across MOIs within each time point. Similar findings have reported that at lower bacterial
numbers per neutrophil, cells can phagocytose and kill Aa efficiently (111, 263). This
suggests that the known cytotoxic activities of LtxA are concentration dependent. LtxA
mode of action involves binding to the lymphocyte function-associated antigen-1 (LFA-1),
in the presence of cholesterol it leads to clustering of LFA-1 in lipid rafts (264, 265). Pore
formation occurs and triggers the passive efflux of potassium ions and influx of calcium
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ions, ultimately leading to membrane destabilization (263, 266). Therefore, we evaluated
the membrane integrity of neutrophils using an impermeable dye and observed loss of
membrane integrity during infection with Aa.
Quantification of dye translocation into cells resulted in 56.5% of dye positive
neutrophils by 5 mins and increasing to 88% by 15 mins, but with minimal cytotoxicity.
However, cell morphology was round with lobulated nucleus as visualized by confocal and
flow cytometry imaging. Host cells have evolved membrane repair mechanisms as a
counter defense from pore-forming toxins. Two repair mechanisms have been broadly
discussed and they rely on the number and size of the pores, and cell type. The first, is
known as ectocytosis, involves the externalization of microvesicles (267-270). The second
is the endocytic method, where the membrane-pore containing portion is internalized and
targeted to the lysosome for degradation (271, 272). It can be proposed that neutrophils can
make use of one of these membrane repair mechanisms, most likely the endocytosis
method due to the cytoplasmic vacuoles observed, or another similar mechanism to heal
membrane injuries created by the toxins. Identifying the type of vacuoles and their contents
in neutrophils challenged with Aa 652 will provide information of the potential use of
membrane repair mechanisms and if these are used, it will shed light in what type of repair
mechanisms is.
Previous studies have indicated that calcium influx induced at sublytic levels by
RTX toxins promotes inflammatory responses (273-275). Particularly, at sublytic doses of
RTX toxins, neutrophils are induced to undergo oxidative burst, degranulation, inhibit cell
mobility, chemotaxis, phagocytosis and even killing by disruption of the phagosome (110,
182, 276). Previously, we demonstrated that neutrophils challenged with a minimally
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leukotoxic strain undergo granule exocytosis and not cell lysis (210). Here, we presented
evidence that neutrophils were functionally active by their capacity to internalize bacteria.
Aa was internalized by neutrophils at MOI 10 but resisted phagocytosis at a MOI of 50.
Further, we found that heat killed bacteria was readily phagocytosed by neutrophils. To
our surprise, JP2 ΔLtxA bacteria resisted phagocytosis to a lesser extent than Aa 652,
suggesting that resistance to phagocytosis by neutrophils is not solely due to LtxA. We also
compared the effects of sublytic and hyper-leukotoxic levels of LtxA in phagocytosis. We
observed that fewer JP2 cells were internalized at MOI 10 and 25, but future quantified
experiments are required to support our observations. As expected, neutrophils underwent
cell lysis at higher MOIs (50, 100) of JP2. Together, our findings support the previously
discussed statement that Aa resists phagocytosis regardless of LtxA expression (129, 260).
A potential scenario for Aa resistance of neutrophils internalization is a cooperative effect
of LtxA and other virulence factors, such as complement inhibition by LPS, Omp29 and
Omp100 (125, 127). Also, the expression of tad fimbriae (absent in lab stocks) has been
shown to be important in resistance of neutrophil phagocytosis (129, 257).
We observed cytoplasmic vacuoles in neutrophils challenged with Aa at MOI 10
for 2h. The formation of these vacuoles has been associated with pore-forming toxins, such
as Helicobacter pylori VacA (277, 278). The concentration and exposure time of cells to
the pore-forming toxins determines if a cell commits to a cell death pathway (58, 60-62).
In line with this, at MOI 10 and 25 we found vacuoles at all time points when neutrophils
were challenged for, e.g., 0h, 0.5h, 1h and 2h with Aa 652. JP2 induced cytoplasmic
vacuoles only at the lowest MOI of 10 and cell lysis, in less than 30mins, at MOI 25.
Unexpectedly, JP2 ΔLtxA induced cytoplasmic vacuolation to a similar extent as Aa 652,
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at both MOIs. This suggests that LtxA, although a pore-forming toxin, does not participate
in the induction of cytoplasmic vacuoles in human neutrophils. To directly determine if
LtxA plays a role in cytoplasmic vacuolation, neutrophils can be challenged with purified
recombinant LtxA to evaluate the formation of cytoplasmic vacuoles. In the case that
purified LtxA does induce cytoplasmic vacuolation, vacuolization may occur by increasing
cytosolic calcium ions due to the creation of membrane pores, which promotes NLRP3
inflammasome activation (279, 280). Another way that cytosolic calcium levels can
increase is through Siglec-9 activation. As shown by von Gunten et al. (64) inhibition of
the NADPH oxidase prevents ROS production and results in reduced or no Siglec-9
activation. Therefore, Siglec-9 activation appears to activate NADPH oxidase and increase
ROS production, which in turn will activate the inflammasome. Wu et al. (84)
demonstrated this in mice; further they identified the ITIM domain of Siglec-E as critical
for ROS production. This group also presented evidence that Gram-negative bacteria
enhance Siglec-9 expression in murine neutrophils, whereas Gram-positive bacteria
suppress expression. Supporting these findings, we demonstrated that Aa enhances Siglec9 expression at MOI 10, 50, 100 in human neutrophils. A peak was observed at MOI 50
and a decrease at MOI 100, although still significant compared to UT. This suggests that
neutrophils may have reached a threshold of membrane damage that they can withstand,
once this threshold is crossed, cells may commit to a cell death pathway. Experiments
evaluating cell death markers will aid to shed light in this. Priming of neutrophils with IL8, but not TNF-α prior to Aa challenge further increased Siglec-9 expression. Both
cytokines are known to be bound and internalized by the outer membrane lipoprotein
bacteria interleukin receptor-1 (BilRI) in Aa (228). LPS from Aa binds IL-8 which
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contributes to modifications of the composition of the extracellular matrix in biofilm and
further activates neutrophils, whereas TNF-α favors LtxA induced apoptosis by
upregulating LFA-1 expression (229, 230, 281). Our experiments of neutrophils challenged
with the Gram-positive oral pathogens Ps and Fa were contradictory. A potential
explanation for our observations is that F. alocis activates NF-κβ through TLR2 signaling
(262). Following, NF-κβ activates the transcriptional factor AP-1, that binds to the SiglecE (Siglec-9 homolog in mice) promoter (84). This suggests that Gram-positive bacteria
suppression of Siglec-9 expression may rely on the non-canonical signaling pathway after
TLR binding. Initial experiments showed that Gram positive bacteria increased Siglec-9
expression, although not to the extend induced by Aa 652. On the other hand, a second set
of experiments showed that Ps and Fa did not induce increased expression of Siglec-9,
similar to what it was shown by Wu et al. (84). In summary, LtxA does not play a major
role in inducing cytoplasmic vacuoles in human neutrophils, but Aa may induce vacuole
formation through Siglec-9 activation.
In conclusion, we show that LtxA alone does not confer full protection to Aa from
phagocytosis, particularly at sublytic levels. We propose that human neutrophils can
withstand a certain level of membrane injury by LtxA. However, once the threshold is
crossed, the cell will commit to a cell death pathway. Given that pore-forming toxins
induce cytoplasmic vacuoles, we initially hypothesized that LtxA was responsible for
inducing cytoplasmic vacuoles in Aa, but the experimental evidence does not support this
outcome. Thus, Siglec-9 activation represents an alternative pathway for inducing
cytoplasmic vacuoles. We showed that Aa enhances Sglec-9 expression and the expression
was increased when neutrophils were primed with IL-8 but not TNF-α. We propose a
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scenario where at sublytic levels of LtxA, neutrophils withstand membrane injuries
repaired by the endocytosis method membrane repair mechanism. Aa interaction with
neutrophils leads to Siglec-9 activation which could involve NLRP3 activation and ROS
production, resulting in cytoplasmic vacuoles formation. The findings presented in this
chapter serve as a foundation for further studies of LtxA sublytic activity in neutrophils
and how Aa modulates the inflammatory response of neutrophils through Siglec-9.
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Figure 5.2. Human neutrophils membrane integrity is compromised when challenged with
A. actinomycetemcomitans at MOI 50. Human neutrophils (3x106 cells/ml) were exposed

to increasing MOIs of Aa (5-50) for 0, 15, 30, 60, 120 and 240 mins shaking in water bath
at 37°C. Neutrophils cytotoxicity was determined by measuring released lactate
hydrogenase (LDH) using a colorimetric assay and was presented as percentage of
neutrophil cytotoxicity ± standard deviation (282) of 3 independent experiments.
Statistical significance was determined with Two-way ANOVA with Tukey post-test (A). The
membrane of neutrophils was stained with wheat germ agglutinin (WGA) and membrane
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integrity was determined by the amount of WGA that enter cell. CFSE was used to label
bacteria (B).
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Figure 5.3. Human neutrophils membrane integrity is compromised by 15 mins of A.
actinomycetemcomitans challenge. Human neutrophils (4x106 cells/ml) were challenged

with Aa (MOI 50) for 5, 15, 30, 60 and 90 mins in suspension, shaking in a water bath at
37°C. The integrity of the membrane was evaluated by staining the cells with TO-PRO-3
stain (an impermeable DNA stain) and visualized by imaging flow cytometry (A). PMNs
were classified and quantified as positive or negative by the ability of the impermeable
stain TO-PRO-3 to enter and stain the nucleus. Percentage of positive or negative
neutrophils for TO-PRO-3 was plotted with ± SD of 3 independent experiments (B).
Statistical analysis was determined with Two-way ANOVA with Tukey post-test |
Significance: * p ≤ 0.05, ** p ≤ 0.01, *** p ≤ 0.001.
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Figure 5.4. Human neutrophils can phagocytize A. actinomycetemcomitans at MOI 10.

Human neutrophils (4x106 cells/ml) were challenged with Aa (MOI 10) or Fa (MOI 10) for
15, 30, 60 mins in suspension, shaking in a water bath at 37°C. Following, each condition
was mounted and fixed into a coverslip and bacteria was differentially stained with a
mouse polyclonal anti-Aa (1µg/ml) primary antibody. As secondary antibodies: goat anti115

mouse Alexa Fluor 488 (all Aa) and goat anti-mouse Alexa Fluor 647 (inside Aa). Example
confocal images of differential staining (A), a total 100 neutrophils per donor were counted
and determined if Fa (B) and Aa (C) were internalized. Plotted are the percentage of
neutrophils that internalized bacteria, have associated bacteria or no bacteria ± SD of 3
independent experiments. Statistical analysis was determined with Two-way ANOVA with
Tukey post-test | Significance: * p ≤ 0.05.
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Figure 5.5. A. actinomycetemcomitans resists internalization by human neutrophils at high
MOIs. Human neutrophils (4x106 cells/ml) were challenged with Aa 652, HK Aa 652, JP2,

JP2 ΔLtxA at increasing MOIs of 10, 25, 50 and 100. Representative images are shown of
neutrophils challenged for 30 mins in suspension (A). Cells were challenged for 15, 30, 60
shaking in a water bath at 37°C. After washes, each condition was mounted and fixed into
a coverslip and bacteria was differentially stained with a mouse polyclonal anti-Aa (1µg/ml)
primary antibody. As secondary antibodies: goat anti-mouse Alexa Fluor 488 (all Aa) and
goat anti-mouse Alexa Fluor 647 (inside Aa). Plotted are the percentage of neutrophils (B)
that internalized bacteria, have associated bacteria or no bacteria ± SD of 3 independent
experiments. Statistical analysis was determined with Two-way ANOVA with Tukey posttest | Significance: * p ≤ 0.05. Number of internalized bacteria is shown for each condition
(C).
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Figure 5.6. A. actinomycetemcomitans induces cytoplasmic vacuoles in human neutrophils
regardless of LtxA expression with minimal cytotoxicity. Fresh Human neutrophils (4x106

cells/ml) were challenged with different Aa strains in suspension for up to 2h at 37°C
shaking in a water bath. After challenge, a volume of 200 μl was collected at each time
point and immediately taken to cytospin and Hema3 staining. Black arrows indicate
cytoplasmic vacuoles. Cytospins images of neutrophils challenged with Aa, JP2 and JP2
ΔLtxA at MOI 10 (A). Cell supernatants were used to measure LDH using a colorimetric
assay. Percentage of cytotoxicity of seven independent experiments is plotted (B).
Cytospins images of neutrophils challenged with Aa, JP2 and JP2 ΔLtxA at MOI 25 (C). Mean
cytotoxicity ± SD was plotted. Statistical analysis was determined with Two-way ANOVA
with Tukey post-test. | N = 7 | Significance: * p < 0.05, ** p < 0.01.
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Figure 5.7. A. actinomycetemcomitans challenge results in increased Siglec-9 expression in
human neutrophils. Human neutrophils (4x106 cells/ml) challenged with Aa at MOI 10 in

suspension for 2h at 37°C shaking in a water bath. Primed neutrophils were incubated with
IL-8 (10ng/ml) for 1h prior to bacterial challenge. Representative flow cytometry histogram
profile (left panels) is provided for each set of conditions: Aa 652 (A), Peptoanaerobacter
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stomatis (Ps) (B) and Filifactor alocis (Fa) (C). The MFI ± SD for Siglec-9 membrane
expression is plotted. Statistical analysis was determined with Two-way ANOVA with Tukey
post-test| N = 5 | Significance: * p < 0.05, ** p < 0.01, *** p < 0.001
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Figure 5.8. A. actinomycetemcomitans challenge enhances Siglec-9 expression in a dose
dependent manner. Representative flow cytometry histogram profile (A). Human

neutrophils (4x106 cells/ml) challenged with Aa (MOI 10/50/100), Ps (MOI 10) and Fa (MOI
10) in suspension for up to 2h at 37°C shaking in a water bath (B-C). Primed neutrophils
were incubated with TNF-α (2ng/ml) for 15 min prior to bacterial challenge (C). Statistical
analysis was determined with Two-way ANOVA with Tukey post-test | N = 4 | Significance:
ns = not significant, * p < 0.05, ** p < 0.01, *** p < 0.001, **** p < 0.0001
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CHAPTER 6
SUMMARY AND FUTURE DIRECTIONS

Epinephrine interaction with Aa requires the expression of QseC periplasmic domain
and FepA, but not YgiW
The QseBC TCS is associated with quorum sensing and is highly conserved in
Enterobacteriaceae and Pasteurellaceae (89) but the signal recognized differs among
species. In Aa, the qseBC operon encodes the genes for QseC, a sensor molecule, and QseB
the response regulator (88). Previous findings made by our group identified catecholamines
(norepinephrine and epinephrine) and iron as the signals sensed by QseC and that the
periplasmic domain of QseC is required for qseBC operon expression (91). At this time the
details of interaction between Cat-Fe and QseC had not been determined. Recently, we
published findings that demonstrated that QseC, in particular the QseC periplasmic
domain (QseC-pr) is required for epinephrine interaction with Aa (210). Moreover,
there is the potential for iron or Cat-Fe to interact with QseC. The QseC sensor protein is
structurally and functionally conserved in Enterobacteriaceae and Pasteurellaceae. In
E.coli, QseC is not directly activated by iron but as a result of iron activating the PmrB
sensor, which activates the PmrA regulator that ultimately binds QseB and induces the
expression of the qseBC promoter (89). Although, Aa does not have the pmrAB genes, the
sequence where QseB binds in the qseBC promoter is identical to that of PmrA binding
site on the pmrAB promoter (89). The subgingival pocket where Aa is found is an
125

environment rich in catecholamines, for this reason Aa has evolved to take advantage of
epinephrine/norepinephrine from the host to acquire ferrous/ferric iron and integrate this
to the sensory functions of the PmrAB and QseBC TCS of E.coli. To determine if
catecholamines and/or iron bind directly to QseC-pr, transformed E.coli BL21 cells that
overexpress QseC-pr (pDJR1, with GST tag, Table 2.1) can be used to express QseC-pr by
IPTG induction (see Chapter 2 for methods). The isolated protein can be used in
equilibrium microdialysis experiments, where the protein of interest is added to one
chamber and the ligand into another with a cellulose membrane (5kDA cut off) between
them (see Chapter 2 for methods). This not only allows the determination of epinephrine
or iron binding with QseC-pr, but the disassociation constant (Kd) can be measured.
Finally, iron abundance in each chamber could be determined by ICP-MS, if a higher
abundance is detected in the chamber containing QseC-pr, it will suggest interaction with
iron. To confirm our results of the requirement of QseC-pr for epinephrine interaction with
Aa, a similar approach can be used by replacing iron with epinephrine as the ligand. In the
case that no interaction is determined with epinephrine or iron alone, Epi-Fe potential to
bind QseC-pr can be investigated as well. Alternatively, a radioactively labeled epinephrine
or iron could be used to assess binding to QseC. These experiments will allow to determine
if Epi/Fe interact with QseC directly and if they interact as a complex or individually.
In both Enterobacteriaceae and Pasteurellaceae, the qseBC locus is associated
with the ygiW gene, which encodes a putative periplasmic protein of the bacterial oligonucleotide/oligosaccharide-binding (OB)-fold (BOF) family (159, 160). In this work we
showed that epinephrine interacts with Aa independently of ygiW expression.
Members of the BOF family can act as scaffolds in ligand binding (160). Although little
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characterization of BOF proteins exist, they have been linked to stress responses (161,
162). CusF, a BOF protein part of the CusCFBA copper-efflux system in E. coli was shown
to bind copper and serve as a shuttle of copper, increasing the accessibility of copper in the
periplasmic space (211). Preliminary observations by a previous lab member indicated that
there was no induction of the qseBC operon in the presence of Cat-Fe in Aa when ygiW
was not expressed (data not shown). To determine if YgiW plays a role in QseC activation,
protein interaction of YgiW and QseC can be determined by pulldown assays. While we
do not fully understand the role of YgiW in Aa at this time, is possible that YgiW in Aa
shares similarities in metal binding with other BOF proteins involved in stress responses,
but this requires further exploration. Future studies can determine if YgiW directly interacts
with iron by utilizing transformed E.coli BL21 cells that overexpress YgiW (pDJR3, with
HIS tag, Table 2.1) after IPTG induction. The equilibrium microdialysis approach
described above can be applied to determine if YgiW binds to iron or epinephrine as a
complex, or individually at the same time. Results will provide insight into the potential of
YgiW serving as a shuttle of iron and/or Epi-Fe and activating QseC. If this is the case, it
will suggest that QseC is indirectly activated by iron, similar to the PmrAB TCS in E. coli.
When Aa was grown in the presence of catecholamines and iron, the enterobactin
operon which contains a gene for FepA, was the only iron acquisition system that was
unchanged (91), suggesting that it may be the main transporter for Cat-Fe into the
periplasm. Using a fepA mutant strain of Aa we showed that interaction of epinephrine
with Aa decreased in the absence of FepA. However, because this interaction was not
completely inhibited, FepA may not be the sole transport system for Cat-Fe. The
importance of FepA in the induction of the qseBC operon and Aa growth can be determined
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using a fepA mutant expressing the lacZ gene (pDJR29). Radioisotopes of epinephrine and
iron can also be used to investigate binding to FepA. Finally, the role of FepA in virulence
can be investigated using the oral gavage mouse model and the Aa fepA mutant strain and
measure bone resorption.
In E. coli, FepA is an outer membrane protein that serves as a receptor for the ferric
enterobactin siderophore (239, 240). The uptake of this siderophore into the bacterial cells
is TonB-dependent (240, 241) and a region of FepA that lies outside the TonB box, is
highly conserved among the Pasteurellaceae family (283). Expression of the FepA
receptor which binds to catecholamines provides Aa the ability to acquire either ferrous or
ferric iron and may provide Aa a competitive advantage against bacteria that do not have
the ability to exploit these molecules. It is also possible that Aa may bind siderophores
produced by other bacteria to acquire iron.
In healthy individuals, transferrin and lactoferrin in serum are only 30% saturated
with iron, maintaining free iron levels at low levels that does not support bacterial growth.
Catecholamines (i.e. norepinephrine) have a higher affinity for iron than transferrin or
lactoferrin and can extract iron from these proteins, making iron readily available to
bacteria (178).
We propose a model (Figure 6.1) where Aa uses epinephrine and iron from the
environment as environmental cues to regulate gene expression that will facilitate
adaptation to the anaerobic environment. Aa exploits epinephrine from the environment as
a pseudosiderophore to sequester iron. Epinephrine and iron interact with FepA which
helps transport iron into the periplasm in a TonB-dependent manner. In the periplasmic
space, it is possible that iron is bound by YgiW, either in complex with the catecholamine
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or independently. Given this, YgiW may serve as a shuttle of iron and/or epinephrine to
activate QseC. Ultimately, iron is transported into the cell by an ABC transporter. Upon
QseBC activation, iron uptake genes are downregulated except for ferritin, which is
significantly upregulated by 10-fold (91). This suggests that Aa is in an iron replete
environment, where high affinity uptake systems for iron are not necessary and their
expression is downregulated to maintain iron homoeostasis. In contrast, ferritin expression
is upregulated to safely sequester iron for storage, to prevent damage due to radical
formation. Confirming this proposed model will provide a better understanding of the role
that QseBC TCS signaling plays in Aa to acquire iron and may facilitate the development
of therapies that will target critical steps to halt bacterial growth or the regulation of genes
that favor bacterial survival in the anaerobic environment.
Human

neutrophils

store

epinephrine

in

azurophilic

granules

and

A.

actinomycetemcomitans gains access to epinephrine by inducing degranulation
Marino et al. (224) detected catecholamines in the supernatant of human peripheral
blood mononuclear cells but the report failed to determine if these catecholamines were
released, and if so, what stimuli induced release. Based on work by others, it is known that
there is a large infiltration of neutrophils at the subgingival pocket during periodontitis (27,
35, 231) and murine neutrophils have been shown to release and synthesize catecholamines
when stimulated with LPS (166). We expanded the current knowledge by
demonstrating for the first time that human neutrophils store endogenous
epinephrine in azurophilic granules, and that by inducing degranulation, Aa
promotes the release of epinephrine. Further, under anaerobic conditions we showed
that neutrophil-derived epinephrine can facilitate iron acquisition, promote Aa
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growth and induce the qseBC operon. The use of host-derived catecholamines by Aa is
also observed in B. bronchiseptica, B. pertussis and E. coli, which have been shown to use
norepinephrine from the host to sequester iron from iron-loaded transferrin (137, 138, 154).
It has been published that other Gram-negative bacteria, such as Y. enterocolitica, P.
aeruginosa and E. coli, show a drastic increase in bacterial growth in the presence of
epinephrine, norepinephrine, dopamine and dopa (176). The bacterial evolution to use hostderived catecholamines to adapt to environmental changes and persist serves as an example
of convergent evolution.
As previously shown in our lab, this promotes the downregulation of genes involved
in iron uptake and upregulates the expression of genes involved in anaerobic respiration
and iron storage (91). Adding to the findings of the previous section, our in vitro results
would suggest that in the subgingival pocket, human neutrophils may serve as an
epinephrine source for Aa and provide an environment that may facilitate iron acquisition.
To confirm if our in vitro findings that neutrophils serve as a source of epinephrine to Aa
are recapitulated in vivo, we propose to use the experimental periodontitis model where
mice are oral gavaged with Aa, followed by administration of a micro-dose (284) of TATfusion proteins, Syntanxin4 and SNAP23 (199), to selectively inhibit the release of
granules in neutrophils. The inhibition of release of secretory vesicles and specific and
azurophilic granules in murine neutrophils will be confirmed by measuring granule
membrane markers by flow cytometry. Inhibition of release of gelatinase granules will be
determined by measuring MMP9 release into supernatant. The levels of epinephrine in
blood will be measured by ELISA. The impact that inhibition of degranulation in murine
neutrophils has in Aa inducing bone loss will be measured. As controls untreated mice and
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Aa-only infected mice will be used. This approach will allow to determine if neutrophils
are the main source of epinephrine for Aa. There is not enough information of other bacteria
that normally is found in co-infection with Aa to exploit neutrophil degranulation.
However, the competitive advantage or benefit of neutrophils degranulation in other oral
bacteria can be explored by co-infection of Aa with other bacteria that is normally found
with in vivo, such as Filifactor alocis.
In our epinephrine release experiments, we observed the levels of epinephrine in
cell lysates increased after 8h and 24h of bacterial challenge (Figure 4.2.C-D) suggesting
de novo catecholamine synthesis by human neutrophils. We showed that during Aa
infection human neutrophils have significant levels of tyrosine hydroxylase, the
enzyme that catalyzes the rate limiting step of catecholamine synthesis (Figure 4. 5.A),
expanding previous observations (234). However, dopamine β-hydroxylase, which
catalyzes dopamine into norepinephrine, decreased during Aa infection (Figure 4.5.B).
This result can be explained by the fact that not all dopamine will be made into
noerpinephrine, therefore less demand for this enzyme. We also demonstrated that the
catecholamine inactivating enzymes catechol-o-methyltransferase and monoamine
oxidase-A increased during Aa infection at 4h (Figure 4.5.C-D), the same time point we
see a peak in epinephrine release induced by Aa (Figure 4. 2.A). This suggests an increase
requirement for catecholamine inactivation enzymes due to increased epinephrine release.
In vivo, catecholamine levels are tightly controlled in different ways, such as by
inactivation, at which state does not promote bacterial growth (154). It would be of interest
to determine if the expression of these enzymes changes in neutrophils during Aa
challenge. qRT-PCR at different time points during bacterial challenge will allow to
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determine changes in gene transcription. These findings will provide information of the
catecholamine turnover in neutrophils during Aa challenge.
We propose a model (Figure 6.2) where the encounter between neutrophils and Aa
in the subgingival pocket promotes azurophilic granule exocytosis, and release of
epinephrine. Consequently, epinephrine storage is depleted promoting catecholamine
metabolism (210). In an environment where immune cells are releasing antimicrobials like
lactoferrin and transferrin to starve bacteria by sequestering iron, and other bacteria release
siderophores to acquire iron, Aa has the advantage of using epinephrine to acquire iron,
promoting Aa growth and induction of the qseBC operon. Potential future therapies can
target catecholamines for inactivation by complexing them with albumin or by sulfonation
will render them useless to Aa to sequester iron (154) and prevent bacterial growth.
Effect of LtxA sublytic levels in neutrophil functions
The toxic effects of LtxA are highly dose dependent, as sublytic concentrations of
the toxin not only induce increased calcium transport into cells but also activate neutrophils
to promote oxidative burst and degranulation (273, 276). In agreement with this, we
demonstrated that challenge of human neutrophils with the minimally leukotoxic
strain Aa 652 induces the mobilization of secretory vesicles, gelatinase granules,
specific granules and azurophilic granules. Johansson et al. (110) showed that purified
leukotoxin A at high concentration induced release of granule contents from human
neutrophils, and the authors observed increased expression of CD63 and CD66b along with
the release of elastase and lactoferrin. However, these studies used high concentration of
recombinant LtxA that most likely induces cell lysis, and the study did not differentiate or
determine if the release of granules observed was due to true degranulation or cell lysis.
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Both Aa 652 (minimally leukotoxic) and JP2 (highly leukotoxic) are found in periodontitis
patients, therefore it is worth to determine if LtxA plays a role in inducing degranulation.
For this, neutrophils can be challenged with JP2 ΔltxA strain and compared to JP2.
Alternatively, neutrophils can be challenged with recombinant LtxA, to establish a direct
role of LtxA in inducing degranulation. In addition, TEM and apoptosis markers could be
used as well to determine if what we observed is due to degranulation or cell lysis. The Aa
652 strain can be used as an additional control to latrunculin and fMLF, given that we have
establish that induces release of all granules in human neutrophils.
In contrast to the suggested LtxA dose dependent protective effect of Aa to resist
internalization, it has also been argued that Aa resists neutrophil internalization and killing
regardless of leukotoxin phenotype (129, 260). Supporting this, we found that Aa 652 was
internalized by neutrophils at low MOIs, but it resisted phagocytosis at higher
population numbers (MOI 50). Although this would argue that phagocytosis resistance
by Aa 652 is due to more bacteria producing LtxA, we showed that Aa 652 challenge at
MOI 50 extended the life span of neutrophils for 24h (Figure 4.4.C) with minimal
cytotoxicity (Figure 5.3.B) compared to JP2 challenge at MOI 10 for 30 mins (Figure
5.6.B). Interestingly, the JP2 ΔLtxA resisted phagocytosis to a lesser extent than Aa 652,
suggesting that resistance to phagocytosis by neutrophils does not require LtxA. On
the other hand, JP2 was internalized by neutrophils only at low MOIs and as bacterial
population numbers increased, we observed greater cell lysis. The self-aggregating
phenotype and the expression of tad fimbriae (absent in lab stocks) has been shown to be
important in resistance of neutrophil phagocytosis (129, 257). A potential scenario for Aa
resistance of neutrophils internalization is a cooperative effect of LtxA and other virulence
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factors. Other virulence factors that have been suggested to play a role in resistance of
phagocytosis are complement inhibition by LPS, Omp29 and Omp100 (125, 127). Omp29
is known to bind C4-binding protein, inhibiting the activation of the classical and mannosebinding lectin (124) complement pathways (125). Omp100 captures the alternative
complement pathway negative regulator, Factor H, and deposits it at the cell surface to
inactivate C3b (127). In addition, to using unopsonized bacteria, all these genes are present
in the strains we used, possibly explaining why Aa was able to resist internalization by
neutrophils. To confirm this, Aa mutants for Omp29 and Omp100 can be tested for their
ability to resist phagocytosis by human neutrophils.
Pore forming toxins, such as LtxA, are associated with the formation of vacuoles
in cells due to exposure to bacterial or viral pathogens, a phenomenon known as
cytoplasmic vacuolation (277, 278). We showed that Aa induces cytoplasmic
vacuolation in neutrophils, but unexpectedly, the JP2 ΔltxA induced cytoplasmic
vacuolation similarly to Aa 652, at MOIs from 10 to 50. Therefore, Aa appears to
induce cytoplasmic vacuolation in human neutrophils independently of LtxA.
Although, our results suggests that Aa induces cytoplasmic vacuolation independently of
LtxA it does not eliminate a potential role of LtxA in inducing these vacuoles. Therefore,
it is worth to confirm our observations by directly exposing human neutrophils to purified
LtxA and evaluate the formation of cytoplasmic vacuoles. Further, to determine if there is
significant difference in vacuoles formation numbers between Aa and JP2 ΔLtxA,
quantification of cytoplasmic vacuolation can be done using transmission electron
microscopy (TEM).
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Finally, we found that neutrophils were experiencing loss of membrane
integrity, but our observations suggests that neutrophils can withstand the effect of
LtxA at sublytic levels and potentially employ membrane repair mechanisms to heal
membrane injuries created by the toxin. This would be relevant in patients with
periodontitis caused by Aa 652, where neutrophils will be exposed to sublytic levels of
LtxA that can cause membrane damage and yet not cell lysis. However, this brings into
question if it is energy favorable for the cell to repair such damage. The repair mechanism
selected by the cell relies on the number and size of the pores, and cell type. Two potential
membrane repair mechanisms that can be used by the cell are the ectocytosis method which
it involves the externalization of microvesicles (267-270), and the endocytic method that
consists of internalization of the membrane-pore containing portion that is targeted to the
lysosome for degradation (271, 272). It will be of interest to determine what type of
membrane repair mechanism is used by neutrophils after LtxA damage by Aa. In addition,
identifying the type of vacuoles and their contents in neutrophils challenged with Aa 652
will provide information of the potential use of membrane repair mechanisms and if these
are used, and it will allow to determine if the cytoplasmic vacuoles induced by Aa are
associated with membrane repair processes. Further, identification of vacuole type and
contents through TEM may provide information of what type of membrane repair system
or cell death pathway is activated in the neutrophils in response to Aa 652.
A. actinomycetemcomitans increases Siglec-9 expression in human neutrophils
Wu et al. (84) showed that murine neutrophils challenged with Gram-negative
bacteria exhibit increased Siglec-9 expression in neutrophils, whereas Gram-positive
bacteria suppress expression. We expanded this finding by showing that an oral
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bacterium, Aa, enhances Siglec-9 expression at MOI of 10, 50, and 100 in human
neutrophils. Further, we showed that pre-treatment of human neutrophils with IL-8
followed by Aa challenge resulted in a significant increase in Siglec-9 expression
compared to Aa challenge alone.
Siglec-9 has been associated with the formation of cytoplasmic vacuoles (63).
Activation of Siglec-9 in a pro-inflammatory environment diverts to a caspase-independent
cell death, ROS production and vacuole formation (86). Additionally, Zeng et al. (83)
demonstrated that Siglec-E (the Siglec-9 mouse homolog) is involved in modulating
neutrophil functions, including induction of apoptosis both independent and dependent of
caspase activation. To supplement our preliminary findings and determine if neutrophils
are undergoing apoptosis or another cell death pathway the presence of cell death markers
can be investigated, in addition to the requirement of caspase activation. To determine if
Siglec-9 expression and cytoplasmic vacuolation are related events, Siglec-9 receptor can
be blocked with Siglec-9 F(ab) fragments as previously done by von Gunten et al. (64) and
the ability of Aa to induce cytoplasmic vacuolation can be determined. Because we have
not directly determined if LtxA plays a role in cytoplasmic vacuolation it would be of
interest to determine if LtxA plays a role in increasing Siglec-9 expression, potentially
being the connection between Siglec-9 expression and cytoplasmic vacuolation. To test
this, human neutrophils can be challenged with JP2 and JP2 ΔLtxA compared to Aa 652,
and measure Siglec-9 expression by flow cytometry. In addition, Wu et al. (84) showed in
mice that Gram-negative bacteria resist killing by enhancing Siglec-E expression, therefore
it would be of interest to determine if blocking Siglec-9 has an effect on Aa clearance after
internalization.
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Sialic acid is the main ligand of Siglecs and is used by the host as a surveillance
system to differentiate from self and non-self, and regulate unwanted immune responses
(66-70). However bacteria has evolved mechanisms to exploit this by stealing sialic acid
from host cells and using it as a disguise in order to suppress immune response (70). Aa
has been shown to incorporate sialic acid to its LPS structure, like other Pasteurellaceae
family members to dampen neutrophils inflammatory response (70, 71). To determine the
requirement of Aa LPS for Siglec-9 activation, human neutrophils could be exposed to
purified Aa LPS and evaluated for changes in Siglec-9 expression. This will allow us to
determine if increased Siglec-9 expression in neutrophils is solely due to sialic acid on Aa
LPS or an integrated effect of sialic acid binding and activation of Siglec-9 and TLR4 by
Aa LPS.
Although sialic-acid is the main ligand of Siglec-9 (70), some Siglecs can bind
other type of ligands, such as heat-shock proteins (HSP) (71). Aa is known to express
several HSP and some have been suggested to serve as virulence factors. For example, in
Aa, HSP60, has cross-reactivity with oxidized low-density lipoproteins (LDL) antibodies
and is considered to have a role in the progression of atherosclerosis (285). If a role is
determined for HSP60 in increasing Siglec-9 expression in neutrophils through binding, in
addition to LPS, it will serve as novel advantage for Aa in the oral cavity by having more
than one way to dampen neutrophil inflammatory response. Additionally, it will highlight
the importance of modulating Siglec-9 expression for Aa survival. Given this blocking
Siglec-9 activation can be explored further for therapy uses.
Summarizing the last two sections, presents a scenario (Figure 6.3) where at LtxA
sublytic levels Aa induces degranulation of all neutrophil granules. Aa resists
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internalization by neutrophils at higher MOIs independently of LtxA expression. Other
virulence factors such as Omp29 and Omp100 may be responsible for phagocytosis
resistance, or the resistance is due to a cooperative effect of such virulence factors and
LtxA. Aa challenge of human neutrophils induces cytoplasmic vacuolation independently
of LtxA and it can be due to vacuoles formed by endocytic membrane repair mechanism.
Ultimately, as an effort to suppress the inflammatory response of neutrophils Aa increases
Siglec-9 expression, that is further increased in IL-8 primed neutrophils.
In conclusion, Aa evades internalization by human neutrophils, and it induces
degranulation to access epinephrine and sequester iron. This leads to QseBC activation and
regulation of genes necessary for Aa to thrive and adapt to the anaerobic environment. Aa
modulates neutrophils inflammatory response by increasing the expression of the
inhibitory Siglec, Siglec-9. This way Aa modulates the inflammatory response of
neutrophils to maintain and inflammatory environment that does not eliminate Aa but
provides it with the necessary factors to persist.
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Figure 6.1 Epinephrine interaction with components of the QseBC TCS. We propose a

model where epinephrine and iron bind FepA (A). Both epinephrine and iron are
transported into the periplasm where we found that epinephrin does not interact with
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YgiW (B), but binding of iron alone or of both epinephrine and iron to YgiW may be required
(see insert). Then, YgiW serves as a shuttle of iron and epinephrine to activate QseC which
interacts with epinephrine (C), ultimately leading transport of iron to inside the cell by the
ABC transporter (D) and to QseB activation and expression of the qseBC operon (see
insert).
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Figure 6.2 Model of how A. actinomycetemcomitans access epinephrine released by
human neutrophils. We propose that Aa induces granule exocytosis (A) in human
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neutrophils in order to access epinephrine which is store epinephrine in azurophilic
granules (B). Finally, Aa exploits neutrophil-derived epinephrine to scavenge for iron (C)
promoting growth (D) and induction of the qseBC operon to regulate the expression of
genes for priming anaerobic metabolism (E). Consequently, epinephrine storage is
depleted promoting catecholamine metabolism (F).
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Figure 6.3 Working model of sublytic effects of LtxA on neutrophils and induction of
cytoplasmic vacuolation and increase of Siglec-9 by A. actinomycetemcomitans challenge.

We propose a scenario where at sublytic levels of LtxA, LtxA alone does not confer full
protection to Aa from phagocytosis (A) by human neutrophils and can withstand
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membrane injuries (B) repaired by membrane repair mechanisms. Aa challenge induces
cytoplasmic vacuolation regardless of LtxA expression (C) and it also increases Siglec-9, that
is further increased with IL-8 pre-treatment (D).
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